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modest additive effects on phenotypes.
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ABSTRACT

Reverse genetics methods, particularly the production of gene knockouts and
knockins, have revolutionized the understanding of gene function. High throughput
sequencing now makes it practical to exploit reverse genetics to simultaneously study
functions of thousands of normal sequence variants and spontaneous mutations that
segregate in intercross and backcross progeny generated by mating completely sequenced
parental lines. To evaluate this new reverse genetic method we resequenced the genome
of one of the oldest inbred strains of mice²DBA/2J²the father of the large family of
BXD recombinant inbred strains. We analyzed ~100X whole-genome sequence data for
the DBA/2J strain, relative to C57BL/6J, the reference strain for all mouse genomics and
the mother of the BXD family. We generated the most detailed picture of molecular
variation between the two mouse strains to date and identified 5.4 million sequence
polymorphisms, including, 4.46 million single nucleotide polymorphisms (SNPs), 0.94
million insertions/deletions (indels), and 20,000 structural variants. We systematically
scanned massive databases of molecular phenotypes and ~4,000 classical phenotypes to
detect linked functional consequences of sequence variants. In majority of cases we
successfully recovered known genotype-to-phenotype associations and in several cases
we linked sequence variants to novel phenotypes (Ahr, Fh1, Entpd2, and Col6a5).
However, our most striking and consistent finding is that apparently deleterious
homozygous SNPs, indels, and structural variants have undetectable or very modest
additive effects on phenotypes.
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CHAPTER 1.

INTRODUCTION

INTRODUCTION TO GENOMIC MEDICINE
Genetic variation modulates virtually all aspects of phenotypic variation,
including physiological and behavioral differences, susceptibility to diseases, and
differences in drug responses among individuals within and between populations [1-5].
Identification of the sets of causal genetic variants is fundamental to a better
understanding of molecular mechanisms underlying the heritable fraction of phenotypic
variation. This, in turn, is important for developing more rational, mechanistic, and
individualized strategies for therapeutic intervention.
The last decade has seen a significant shift from family-based linkage studies to
genome-wide association studies [6-8]. The advent of high-throughput genotyping
technology has enabled fast and accurate detection of genotypes for large numbers of
known markers in large human cohorts. This, along with development of advanced
statistical approaches (and ample funding), has propelled a series of systematic gene-todisease association studies. To date, genetic association studies have reliably linked
thousands of sequence variants (mainly SNPs) to a wide-variety of Mendelian and
common complex diseases [9,10].
The dramatic reduction in the cost of high-throughput sequencing and
computational resource required to analyze the data, has also enabled large scale
sequencing efforts with the aim of comprehensive profiling genetic and transcriptomic
differences between case and control cohorts [11-13]. The acquisition, integration and
interpretation of multi-omic data including genomics and its derivatives²
transcriptomics, proteomics and metabolomics²have been successful in the discovery of
biomarkers for diagnostic, preventative and therapeutic purposes. These rapid
developments are facilitating the clinical adoption of genomic medicine²the
FXVWRPL]DWLRQRIWUHDWPHQWUHJLPHQVDQGSKDUPDFHXWLFDOVEDVHGRQDQLQGLYLGXDO¶V
genetic profile [14-16]. Considering the rate at which sequencing technology is outpacing
0RRUH¶V/DZ[17], characterizing genomic variation from personal genome sequencing
will be as affordable as an X-ray scan. Phase I of genomic medicine is already having an
impact on healthcare by offering genome-based diagnostic approaches for the prediction
of disease risks, prediction of drug response, accurate molecular classification of disease,
and early detection of diseases.

IDENTIFICATION OF DISEASE RISK FACTORS²THEN AND NOW
Genetic mapping approaches to identify disease risk factors have evolved largely
during the last three decades [18,19]. This is mainly due to advances in the definition of
chromosomal markers, and in related sequencing technologies. Advanced study-designs
and statistical methods have shifted the focus of genetic research from studying rare
disorders within families, to studying common and complex disorders segregating within
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large populations. The new methods have allowed us to dissect the genetic architecture of
complex disorders including the identification of the causal genomic loci, estimation of
the disease heritability, estimation of effect sizes of different loci and their non-additive
interactions.

Linkage analysis
The earlier breakthroughs in linking genotype with phenotype involved studies of
Mendelian disorders that can be mapped to a single gene and a single mutation. These
studies were often family-based and used linkage analysis to define the candidate
chromosomal region, followed by positional cloning to narrow down the candidate region
to a causal gene. Genetic variation within families was used to construct linkage maps,
and risk loci and genes were mapped to a particular chromosomal location by testing for
co-segregation with small panels of markers²often just a few hundred. The first
successful application of this approach identified genomic loci responsible for an Xlinked phagocytic disorder²chronic granulomatous disease (CYBB) [20]. This was soon
followed by identification of the loci and ultimately genes responsible for other genetic
disorders including Duchene muscular dystrophy (DMD) [21], cystic fibrosis (CFTR)
[22], Huntington disease (HTT) [23,24], polycystic kidney disease (PKD1, PKD2 and
PKHD1) [25-27] , phenylketonuria (PAH)[28], albinism (TYR) [29] and many more.
Currently, Online Mendelian Inheritance in Man (OMIM) catalogues 4,500 human
disorders for which the underlying genetic mutations are known
(http://omim.org/statistics/entry).
The success of linkage analysis and positional cloning was mainly limited to the
identification of high-penetrance monogenic variants that mainly disrupt the structure of
proteins such as huntingtin [30]. However, most genetic disorders including
cardiovascular diseases, diabetes and neurodegenerative diseases are actually the result of
combination of inherited variants in multiple genes that have small or moderate effects
and that often do not modify protein structure at all [31]. For example, a recent study has
identified 108 loci that are significantly associated with schizophrenia none of which
produce known protein differences [32]. For these types of complex polygenic diseases,
family-based linkage studies often suffer from unavailability of family of multiple
generations or sufficient numbers of genetically informative families, particularly for
late-onset diseases such DV$O]KHLPHU¶VDQG3DUNLQVRQ¶V/LQNDJHDQDO\VLVDOVRsuffers
from poor genetic resolution (typically on the order of a few centimorgans). Additionally,
for polygenic disorders it is highly unlikely that every family will be segregating for the
same collection of causal variants (genes) and combining data may adversely affect the
linkage analysis.

Genome wide association studies
The development of the common disease/common variants hypothesis in mid1990s led to the idea of genome-wide association studies (GWAS) [33,34]. This
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hypothesis predicts that common disease-causing alleles will be found in all human
populations which manifest a given disease. In other words, common complex diseases
could be accounted for by a few common variants (minor allele frequency > 5%) with
moderate effects. This led to large-scale human genotyping initiatives such as the
International HapMap Project [35,36] to catalog common genetic variants that are
segregating within and between human populations. The Phase III of this project
genotyped 1.6 million common single nucleotide polymorphisms segregating in 11
human populations, representing multiple ethnicities. Another large-scale genomics
initiative, 1000 Genomes Project, has been using a combination of whole-genome
sequencing, deep exome sequencing, and dense microarray genotyping to establish the
most detailed catalogue of genetic variants (minor allele frequency > 1%) in human
populations [2,5]. The third phase of 1000 Genomes Project has just finished and
generated a haplotype map of 84.7 million SNPs, 3.6 million short insertions and
deletions (indels), and more than 60,000 larger deletions segregating in 26 human
populations [37].
A typical GWAS examines a large number of common genetic variants (500,000
to five million SNPs) in a large number of case and control individuals to identify alleles
associated with a trait or disease. Typically, thousands of individuals are genotyped in
both case and control groups. Allele frequencies for genotypes (SNPs) between two
groups are compared to reveal genotypes that are overrepresented in cases compared to
controls and therefore likely to be associated with disease risk variants. The first
successful GWAS study investigated age-related macular degeneration (AMD) to
identify variants in complement factor H (CFH) as major risk factors [6]. Since then,
there has been a deluge of GWA studies (GWASs) that have identified thousands of
statistically significant SNPs associated with common diseases including coronary artery
disease [38], type 1 and 2 diabetes [8,39,40], bipolar disorder [41], hypertension [7,42]
and many more. Currently, the GWAS catalogue [9] at NHGRI-EBI
(http://www.ebi.ac.uk/gwas/) consists of over 2,000 GWAS publications linking nearly
4,500 statistically significant loci (p < 10-8) to over 500 human traits and diseases.
Extensive cataloguing of common variants and high-throughput genotyping has made
GWAS a well-established method to identify genetic variants for the complex diseases.
Unlike family-based studies GWAS offers the advantage of exploiting unrelated
individuals, making the task of data collection much easier. However, population-based
studies are confounded by population stratification²presence of systematic difference in
allele frequencies between subpopulations due to their different ancestry. As a result, any
SNP with a considerable variation in its frequency between different subpopulations
could be spuriously associated with the disease of interest if these subpopulations
themselves considerably differ in the prevalence of the disease [43]. A number of
statistical approaches have been developed to capture and control for the complex
population structures in GWAS [44-48].
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Electronic medical records
The last decade has also seen rapid growth in efforts to implement electronic
medical records (EMRs) systems in large health care systems. EMR data sets contain rich
and diverse medical information including patient history, diagnoses, prescribed
medications, and quantitative data from many possible clinical tests. The structured and
unstructured information (free-text clinical notes) in EMRs can be extracted using the
defined International Classification of Diseases, version 9 and 10-CM codes [49-51] and
natural language processing approaches. Longitudinal EMR datasets have been used for
observational-based healthcare research to improve patient care [52,53].

Phenome-wide association study (PheWAS): advantages and challenges
Lately, EMR-derived phenotypes have been linked with genotypes to perform
phenome-wide association study (PheWAS) [54-59]. Large scale biorepositories such as
the electronic Medical Records and GEnomics (eMERGE) network [60-65] have been
systematically integrating massive EMR datasets (phenotypes) and DNA biorepositories
(genotypes) for high throughput genome-to-phenome research.
Unlike GWAS that uses a phenotype-to-genotype approach, PheWAS uses a
reverse genetic approach to perform genotype-to-phenotype association. It starts with a
known genetic variant and tests for its association over a wide spectrum of clinical
phenotypes derived from EMRs. The first proof-of-principle PheWAS study was
published in 2010 by Denny et. al [59]. They selected five known disease-associated
SNPs (previously identified by GWAS) and genotyped a cohort of 6,005 patients for
these SNPs. Each of these SNPs was then associated with hundreds of disease codes that
comprised the phenome. The PheWAS recaptured four of the five known SNPs-disease
associations and also found novel associations with other diseases. For example, a SNP
(rs3135388) that was previously associated with multiple sclerosis was also found to be
associated with erythematous conditions. Several recent studies have successfully
exploited PheWAS to identify novel SNP-disease associations [54,57,59,64,66,67].
Whereas GWAS focuses on only one disease at a time, PheWAS has the ability to
measure genetic associations with potentially thousands of traits and diseases
simultaneously, enabling systematic detection of genetic variants with pleiotropic effects
[56,58,67]. This can aid in the repurposing of approved drugs and save enormous amount
of time, money and efforts that go into the therapeutic development and testing process.
For example, variants in TNFSF11DWXPRUQHFURVLVIDFWRUDUHDVVRFLDWHGZLWK&URKQ¶V
disease. Denosumab, a monoclonal antibody that targets TNFSF11 is currently marketed
for the treatment of postmenopausal osteoporosis, but it may also be considered for
&URKQ¶VGLVHDVH[68].
A prerequisite of conducting a PheWAS is the availability of massive phenome
data. As a result, all PheWAS studies have exploited disease phenotypes derived from
EMR datasets. However, in practice PheWAS can be applied to any well-characterized
cohort that have been extensively genotyped and for which deep phenomes have been
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assembled, such as the Framingham Heart Study cohort or the Avon Longitudinal Study
of Parents and Children cohort [69-74]. As I show below it is also possible to conduct a
PheWAS using deeply phenotyped cohorts of model organisms.

GENETIC ASSOCIATION STUDIES IN MOUSE MODEL SYSTEMS
The laboratory mouse has been extensively used as a model organism to dissect
the genetic architecture of complex phenotypes and disorders. Studying complex
phenotypes in mouse offers several advantages over human. First, it is practical to
acquire cellular and molecular traits from disease-relevant tissues and cell types. Second,
it is possible to replicate experiments in reference cohorts (also known as reference
panels or reference populations), which is impossible in humans except for in cases of
monozygotic twins. Third, it is easy to control the environment and model gene±
environment (GXE) interactions in mice [75]. Fourth, despite strong functional effects,
the minor allele frequencies are often too low in the human population to attain sufficient
statistical power and significance in large association studies. In contrast, most of murine
crosses have been derived from two inbred strains, and as a result allele frequencies are
close to 0.5. Fifth, it is possible to perform knockins, knockouts, and knockdowns in mice
to identify the causal gene from the list of candidate genes. Lastly, genetic research in
humans has added complexities including confidentiality constraints and higher ethical
limitations on experimental protocols. Genomic information derived from human
participants especially those in diseased groups is sensitive, and strict guidelines and
policies (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-088.html) must be
followed to protect the privacy and confidentiality of participants and their descendants
[76]. However, one of the main disadvantages of murine cohorts is that linkage
disequilibrium is typically at least an order of magnitude larger than in humans. As a
result, mapping studies using currently available murine populations often identify large
genomic regions with tens to hundreds of candidate genes.

Mapping populations in mouse model systems
Mice cohorts, including F2 intercrosses and backcrosses, heterogeneous stocks
[77], sets of recombinant inbred (RI) strains (e.g., BXD [78], LXS [79], and the
Collaborative Cross [80]) have been extensively used for mapping of both Mendelian and
complex traits. These crosses differ greatly in their genetic diversity, mapping power, and
resolution [81,82]. RI strains are generated by intercrossing two or more parental inbred
strains, followed by repeated sibling matings for at least 20 generations. The repeated
mating of siblings for 20 generations or more generates fully inbred strains. Each RI
strain represents a unique and fixed chromosomal mosaic of the parental genomes. Once
all members of a large set of RI strains have been fully inbred and genotyped, then the set
can be used as an immortal and genetically defined resource²a genetic reference panel.
The historical disadvantage of RI strains was their limited numbers and modest power
and precision of associated QTL studies. Throughout most of the 1990s there were fewer
than 30 strains per family. Now however, three mouse RI GRPs consist of 60 to 150
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strains each (n ~150 for BXD, n ~ 60 for LXS, and n ~100 for the Collaborative Cross)
[79,83]. The main disadvantage of RI strains is not QTL mapping power or precision, but
steadily rising costs of acquisition and maintenance of large numbers of strains.

BXDs²a replicable experimental cohort for genomic medicine studies
The BXD family is made up of ~150 RI strains (some still in progress) that
descend from intercrosses between C57BL/6J and DBA/2J strains (Figure 1-1).
Currently, they are the largest and oldest RI set available [84]. In chapter 2, I have
compared the genome sequences of the parental strains of the BXDs to identify ~5
million sequence variants that are segregating in this family.
The BXD genetic reference panel has been used to study higher-order complex
traits in diverse research domains including neurobiology, physiology, pharmacology and
immunology since the mid-1970s and genetics of gene expression since the early 2000s.
As a result, they have the largest coherent multiscalar phenotype data set (aka
"phenome") for any segregating population, consisting of 5000 diverse phenotypes
(www.genenetwork.org) and many gene expression data sets. Because these strains are
genetically immortal they can be used as a replicable experimental cohort for
personalized genomic medicine studies. The genetic immortality enables assembly of
deep phenomes for the same set of individuals (strains) over time. Additionally, matched
cohorts can be raised in under different environments to study gene-by-environment
interactions. Approximately 120 BXD progeny lines have now been extraordinarily well
genotyped (30 more in progress) and can be exploited to relate sequence variants to
phenotypic differences.
Over the last three decades, the BXD family has been exploited mainly using the
forward genetic approach such as QTL mapping. This approach starts with heritable
differences in phenotypes and defines loci and causal variant. A few recent achievements
using this approach include identifying Ubp1 for blood pressure [85], Aplp for
hypophosphatasia [86], and Mrps5 for longevity [87]. In contrast, a reverse genetic
approach such as PheWAS starts from known sequence variants and identifies
downstream phenotypic effects. A few recent achievements include Comt for a number of
neuropharmocological traits [88] and Per3 for stress/anxiety traits [89]. The availability
of a comprehensive catalogue of genetic variants linked to the deep phenome datasets
make BXDs highly practical to perform the first PheWAS (genome-wide reverse genetic
scan) using a model organism.

GENE EXPRESSION AS MOLECULAR PHENOTYPES
Sequencing of large cohorts has now become fairly straightforward. However,
generating variant data for thousands of individuals has limited predictive value unless
integrated with a wide-spectrum of phenotype data. Large-scale phenotyping especially
of the clinical traits is still intractable due to high cost, difficult implementation, and
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Figure 1-1.

Derivation of the BXD family

Notes. The parental strains are crossed to generate F1 progenies consisting of genetically
identical individuals. F1 individuals are intercrossed to generate F2 individuals. In the F2
population, each individual has a unique genotype due to the recombination of the alleles
from the heterozygous F1 parents. Repeated sibling mating is performed for 20
generations to generate inbred strains.
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ethical restrictions. An alternative is to use molecular phenotypes including transcript,
protein and metabolite abundances and their modifications to study the genetic basis of
differences in disease risk. Gene expression levels are highly replicable and reproducible
and have been widely used as reliable prognostic indicators of diseases [90-92]. Genetic
linkage and association studies on gene expression levels have demonstrated high
heritability [93] indicating that genetic variants often confer disease risks by affecting
gene expression.
The analyses of complex phenotypes in the pre-genomic era focused on coding
variants²including nonsense, missense, and frameshifts variants,²but GWAS studies
conducted over the last decade have demonstrated that a large majority (>90%) of
trait/disease-associated variants are located in non-coding regions of the human genome
[9]. These non-coding variants act by modulating gene expression, and they are the major
causes of variation in susceptibility to complex diseases [94-96]. Similar to classical
phenotypes, gene expression can exhibit Mendelian or multigenic inheritance patterns
and are therefore amenable to association studies. The control of expression is usually
genetically complex (polygenic) and large numbers of other genes and sequence variants
can potentially influence expression of the target transcript or protein. For example a
group of cooperating transcription factors may control expression of a key transmitter
receptor or an ion channel. These effects give rise to so-called trans eQTLs that map far
from the target gene itself²usually on different chromosomes (Figure 1-2a). In contrast,
expression of mRNAs may also be controlled by sequence variants that are in or very
near to the parent gene itself (Figure 1-2b). For example, a polymorphism in a promoter,
enhancer, splice acceptor site, or the 3' UTR of a gene may produce differences in
transcriptional rates, mRNA stability, or ratios of alternative transcripts. When mapping
the expression of mRNAs or proteins, this type of genetic "self-control" produces socalled cis-acting QTLs or cis eQTLs [97]. In short, cis eQTLs are first-order local effects,
whereas trans eQTLs are second-order distant effects.

CURRENT STATUS OF GENOMIC MEDICINE
Current successes of genomic medicine include clinical diagnosis of monogenic
diseases and disorders, improved therapeutic efficacy and safety of drugs, drug
repurposing, and molecular characterization of cancers to select more effective
treatments. However, with the exception of above mentioned clinical applications,
genomic medicine has yet to be embraced to the extent that was initially anticipated
following completion of Human Genome Project [98]. Here we discuss a few examples
of how the early phase of genomic medicine is impacting healthcare.

Better diagnoses and early interventions
Diagnostic kits that allow screening of genetic carriers for disorders including
breast and ovarian cancer (BRCA1 and BRCA2) [99-102], colon cancer (MLH1, MSH2,
MSH6 and PMS2) [103-106], melanoma (CDKN2A) [107], rheumatoid arthritis
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Figure 1-2.

Linkage maps of cis and trans eQTLs in mouse hippocampus

Notes. (a) Gabrg2 expression is controlled by a trans eQTL on Chr 5 at 138 Mb (LOD =
3.94 on the Y axis). The Gabrg2 gene itself is located on Chr 11 at 41 Mb (triangle on X
axis). (b) In contrast, Grin2b expression is controlled by a cis eQTL with a peak LOD
score of 16.73 located on Chr 6 at 135 Mb. This location corresponds precisely to the
location of the Grin2b gene (triangle). The horizontal lines provide genome-wide
significance thresholds for the QTL determined by permutation analysis (upper <.05 and
lower <.63). All data here were generated in GeneNetwork (www.genentwork.org) using
the BXD mouse Hippocampus Consortium M430v2 (Jun06) PDNN array data set
(GeneNetwork.org, accession number GN112, n = 67, probe sets 1418177_at and
1457003_at).
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(HLA-DR4) [108], cystic fibrosis (CFTR) [22], and thrombophilia (FV, FII, MTHFR)
[109-111] have been widely used to guide preventive care. For example, prophylactic
mastectomy or oophorectomy is recommended to predisposed individuals and has shown
to reduce the risk of cancer by 90-95% in women [112]. Similarly, genetic screenings are
available for prenatal and newborns to detect birth defects and genetic diseases including
cystic fibrosis, severe combined immunodeficiencies, phenylketonuria, tyrosinemia,
sickle cell anemia, hearing loss, and congenital heart defects. Currently, testing of 32 core
disorders and 26 secondary disorders is recommended by the U.S. Department of Health
DQG+XPDQ6HUYLFHV6HFUHWDU\¶V$GYLVRU\&RPPLWWHHRQ+HULWDEOH'isorders in
Newborns and Children [113].

Drug response and dosage
Diagnostic kits based on pharamacogenomic markers that type the cytochrome
P450 family²a major subset of all drug metabolizing enzymes in liver² have been
designed to determine therapeutic strategies and effective dosage. For example, CYP2D,
a member of the cytochrome P450 gene family, is responsible for the metabolism of
approximately 25% of all clinically used drugs including codeine, oxycodone and
tramadol (pain), tamoxifen (breast cancer), dextrometorphan and quinidine (neurological
GLVRUGHUV WHWUDEHQD]LQH +XQWLQJWRQ¶V disease), atomoxetine (Attentiondeficit/hyperactivity disorder), citalopram and desipramine (depression), and
fluvoxamine (obsessive compulsive disorders) [114]. Copy number variants (CNVs) in
CYP2D6 control variation in drug response among individuals [115]. Individuals with
multiple copies of CYP2D6 are ultra-rapid metabolizers. They quickly convert codeine
into morphine and may experience potentially dangerous opioid effects. In contrast, poor
or slow metabolizers suffer from poor analgesia.

Accurate classification and customized treatment plans for cancers
High throughput sequencing can accurately determine driver mutations or genes
associated with heterogeneous cancers and aid in a better understanding of disease
pathology, as well as customization of treatment plans. Screening mutations in non-small
cell lung cancer related genes including EGFR, ALK, HER2, KRAS, BRAF, and PI3KCA
helps select targeted therapies based on the driver mutations [116]. For example,
Dabrafenib, an inhibitor of the BRAF protein has shown to be effective against lung
cancer associated with mutated BRAF gene [117]. Targeted treatments based on driver
mutations have shown to increase survival rates compared to non-targeted treatments
[118,119].
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BIOINFORMATIC CHALLENGES FOR GENOMIC MEDICINE

Processing and managing of high-throughput sequence data
High throughput sequencing offers several advantages relative to array-based
genotyping or expression assays. First, unlike genotyping arrays, whole genome
sequencing is not limited to interrogating only known sequence variants. Similarly, RNAsequencing (RNA-seq) enables expression quantification of novel transcripts that are not
represented on arrays. Second, whole genome sequencing makes it possible to detect
large and complex structural variants. These variants are not as common as SNPs but
have significant effects on expression. However, there is a high bioinformatics overhead
required to store and process sequencing data. Sequencing a mammalian genome at 100x
coverage can easily generate up to half a terabyte of raw sequence data. Moreover, size of
the intermediate data generated during the analysis can get nearly double the original
size. Thus, large-scale storage infrastructure and high network bandwidth connection are
essential for massive sequencing projects. Better compression methods to minimize
storage costs are an area of active research. New compression methods including CRAM,
Goby and HDF5 [120-124] to store genomic alignments have been developed. However,
they have not been fully embraced by the next-generation sequencing community due to
their incompatibility with most of the current analysis tools. Unlike arrays, the
computational workflows for high throughput sequencing data analysis are too intensive
to be performed on a desktop computer and require high performance computing clusters
with hundreds of processors. Adaption of cloud computing strategies has been on the rise
and enables users to customize hardware and computational power based on the project
requirements.

Interpretation of the functional impact of the genomic variants
Functional interpretation of genetic variants is crucial to prioritize candidate
variants in association studies. Functional interpretation of coding variants is relatively
straightforward and their impact can be assessed by annotating them against known gene
models. However, our ability to interpret the impact of non-coding regulatory variants is
highly limited despite their known roles in various diseases [95,96]. Early studies to
evaluate the impact of non-coding variants mainly exploited sequence conservation
across multiple species to quantify likely evolutionary constraints on the variant position
[125-130]. Genome wide scans using position weight matrices [131] have also been used
to identify if variants overlap any known transcription factor binding motifs. However,
Schmidt and colleagues have observed large interspecies differences in transcriptional
factor binding regions [132]. Additionally, short matrices have low sequence specificity
and may identify numerous false positive binding sites across the genome [133]. Recent
studies have adopted multi± and integrated ±omics approaches that incorporate a wide
range of annotations to evaluate functional impact of non-coding variants. Khurana and
colleagues [134] used allele frequencies of sequence variants from 1000 Genomes Project
[2] to distinguish deleterious variants from the neutral variants. They proposed that the
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neutral variants have higher derived allele frequency at the population level and
deleterious variants get removed by purifying selection. They then overlapped this
information with functionally non-coding elements identified by Encyclopedia of DNA
Elements (ENCODE) project to identify functionally important non-coding variants.
Combined Annotation Dependent Depletion (CADD) and Genome Wide Annotation of
Variants (GWAVA) are machine learning based approaches that work along the same
line by integrating diverse resources to identify functional non-coding variants [135,136].
Recently, large numbers of genome-wide studies have successfully integrated highthroughput omic measurements, including gene expression and epigenetic variation data
to increase the power for discovery of causal genes and to better understand the possible
molecular and cellular mechanisms of the disease [137-140].

ORGANISATION OF THE DISSERTATION
The work presented in this dissertation is a genome-wide reverse genetics
analysis. We have exploited a large family of recombinant inbred mouse strains²the
BXD cohort to perform a phenome-wide association study to investigate genome-tophenome relations at multiple scales²from mRNA and protein levels to disease risk,
behavior, and environmental interactions.
The second chapter explores the genomic variation between parental strains of
BXDs using deep (~100X) sequence data of the DBA/2J inbred strain. This analysis
revealed considerable genomic variation including ~4.46 million SNPs, ~0.94 million
indels, and 20k structural variants segregating in the BXD family.
The third chapter examines the functional impact of genomic variation on gene
expression using transcriptomic data from isogenic hybrids (C57BL/6J X DBA/2J F1s).
This analysis revealed that cis acting variation in expression is pervasive and is detected
in roughly 50% of all assayable genes in liver. Genes exhibiting high allelic differences
in expression in conjugation with high-impact coding variants should be key molecular
resources for reverse genetics analysis.
The fourth chapter examines the functional impact of genomic variation on a wide
spectrum of high-order phenotypes [141,142] and molecular phenotypes across multiple
tissues [86,142,143]. We successfully replicated almost all of the known genome-tophenome associations in BXDs, and also identified a few novel associations. We
exploited a large human clinical cohort²the Vanderbilt BioVU cohort² for validation
and cross species translation of the novel associations. We demonstrate that phenome
scans can be effective at linking sequence variants to a range of phenotypes and can be
used to identify novel genome-to-phenome relations or validate hypothesized
associations from independent studies.
Finally, the fifth chapter summarizes and discusses the main results of my
dissertation.
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CHAPTER 2.

SEQUENCING AND CHARACTERIZATION OF THE DBA/2J
MOUSE GENOME

SYNOPSIS
The DBA/2J mouse is one of the oldest and widely used inbred strains. It exhibits
many unique anatomical, physiological, immunological and behavioral phenotypes. In
addition, it is one parent of the large BXD family of recombinant inbred (RI) strains±a
widely used murine genetic reference population. The genome of the other parent of this
BXD family²C57BL/6J²has been sequenced and serves as the mouse reference
genome. We sequenced and analyzed the genome of DBA/2J to generate a
comprehensive catalogue of ~5.4 million sequence variants, relative to the reference
genome. These variants segregate in the BXD family, presently comprising of 120+ RI
strains. The variant data can be exploited to initiate reverse genetic analysis of complex
traits, particularly by exploiting high-impact variants including nonsense, frame-shift,
splice-site, radical missense, copy number, and large insertion and deletion that
differentially affect members of the BXD family. The variant catalogue is also essential
for unbiased alignment of RNA-seq and ChIP-seq data generated using BXD strains and
any other cross involving DBA/2J as a parental strain.

INTRODUCTION
The DBA inbred strain has the distinction of being the oldest of all inbred strains.
It was first developed by C.C. Little in 1909 by inbreeding from a stock of mice
segregating for coat color. During 1929-1930, DBA substrains were crossed to establish
new substrains including DBA/1 and DBA/2. The DBA/2 strain was transferred to G. B.
Mider in 1938, and subsequently transferred to the animal facilities of Jackson
Laboratory (J) and National Institute of Health (N) in 1948 and 1951 respectively. Since
then, they have been maintained separately as DBA/2J and DBA/2N lines (Figure 2-1).
DBA/2J is one of the most widely used inbred strains and exhibits many unique
anatomical, physiological, immunological and behavioral phenotypes. A number of these
phenotypes closely mimic human diseases and disorders. A few well known age-related
phenotypes are progressive eye abnormalities and hearing loss are caused by mutations in
Gpnmb [144], and Tyrp1 [145,146] and Cdh23 [147,148] genes respectively. The unique
characteristics of DBA/2J are often contrasted with those of the C57BL/6J inbred strain
that serves as the mouse reference genome. The two strains are genetically highly
divergent and show a wide variety of phenotypic differences. For example, C57BL/6J
and DBA/2J have high and low susceptibility to diet-induced atherosclerosis [149-151];
high and low preference for alcohol and morphine [152-158]; high and low resistance to
influenza infection [159-161]; low and high bone mineral density [162-165]; low and
high susceptibility to audiogenic seizures [166-169]. The high levels of genetic and
phenotypic variation between these strains have made them highly favorable to be used
for genetic linkage studies. Starting in early 1970s, Benjamin A. Taylor at the Jackson

13

Figure 2-1.

DBA/2 breeding history

Notes. DBA/2 is the oldest inbred strain and originated as part of breeding efforts by C.
C. Little around 1930. The DBA/2 strain was transferred to G. Burroughs Mider in 1938,
and subsequently transferred to the animal facilities of Jackson Laboratory (J) and
National Institute of Health (N) in 1948 and 1951 respectively. Since then, numerous
DBA/2 substrains were created by separation and breeding by different vendors, leading
to genetic drift. These nearly identical lines create a valuable genetic resource for
studying the downstream effects of spontaneous and naturally occurring mutations.
Information regarding substrain derivation dates was compiled from individual vendor
Web sites.
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laboratory started intercrossing C57BL/6J and DBA/2J to produce the BXD family of
recombinant inbred strains [170]. Since the early-1970s, the BXDs have been used
extensively to study the genetic basis of complex traits [84]. They have also been used to
study the genetic basis of gene expression since the early 2000s after the advent of highthroughput expression arrays. BXDs are currently the largest (120+ lines and expanding
to ~150) and the best phenotyped genetic reference population. More than 5,000
phenotypes for these strains have been measured and published, and all of these
phenotypes are accessible at GeneNetwork (www.genenetwork.org).
Whole genome sequencing now makes it practical to exploit reverse genetics to
simultaneously study functions of thousands of sequence variants that segregate in
intercross and backcross progenies generated by mating completely sequenced parental
lines [171] ²the BXDs being a prime example. However, the analysis of highthroughput short read data to discover sequence variants is computationally challenging,
and susceptible to errors associated with mapping artifacts and sequencing chemistry. We
followed the best practices for variant discovery to provide the accurate and most detailed
picture of molecular variation between these two genomes to date. In this chapter, we
describe a comprehensive and high confidence catalogue of SNPs, indels, and structural
variants for the DBA/2J mouse strain, the father of the BXD family, relative to
C57BL/6J, the reference strain for all mouse genomics and the mother of the BXD
family. We annotated the sequence and structural variants against mouse gene models to
assign functional consequences. The detailed catalogue of genetic variation segregating
in the BXD family is essential to 1) link high-impact variants with high-order phenotypic
differences; 2) correct for allelic bias in RNA-seq and ChIP-seq read mapping; 3) assay
differential expression of alleles in isogenic heterozygous F1 individuals.

MATERIALS AND METHODS

Genomic data for DBA/2J
We downloaded sequencing data for DBA/2J from the European Nucleotide
Archive, accession numbers ERP000044 and ERP000927 [172]. It consists of eleven
paired-end libraries sequenced on the Illumina GAII. Average read lengths and insertsizes varied between 54±100 nt and 150±600 nt respectively. We also downloaded
sequencing data from the Sequence Read Archive, accession number SRP001135 [173].
This data was generated at UCLA as a part of the DBA/2J sequencing study at UTHSC.
It consists of three paired-end libraries sequenced on the Illumina GAII with read length
of 100 nt and insert-sizes between 250±350 nt.

Read alignment and post-alignment processing
We organized and processed the sequencing data at multiple levels including raw
data for each sequencing lane, aligned reads for each library and combined aligned reads
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for the DBA/2J samples. A variety of post-processing steps were performed on the data
in a sequential manner to improve the alignment and accuracy of variant calls.

Lane level. Reads were trimmed to remove low quality base calls (q < 20) using
Trimmomatic [174] and trimmed reads shorter than 40 nucleotides were removed. Reads
were aligned to the C57BL/6J reference genome (mm10) using Burrows Wheeler Aligner
(BWA version 6.1) [175] with default parameters to generate sequence alignment/map
(SAM) files [176]. SAM files were converted to binary SAM (BAM) format and their
headers were appropriately modified to include generic information such as lane
LGHQWLILHUOLEUDU\LGHQWLILHUHWFXVLQJ3LFDUGµ$GG2U5HSODFH5HDG*URXSV¶ YHUVLRQ
http://picard.sourceforge.net). Base qualities of aligned reads were recalibrated using
Genome Analysis Toolkit (GATK, v2.1- µ7DEOH5HFDOLEUDWLRQ¶[177]. This tool
empirically models errors in assignment of base qualities by the sequencing machine and
generates new qualities that are highly accurate.

Library level. All lanes (BAMs) for each library were merged into one BAM file
XVLQJ3LFDUGµ0HUJH6DP)LOHV¶ PCR duplicate reads (those that map to the same genomic
location as a pair) except the one with the highest sum of base qualities were flagged
XVLQJ3LFDUGµ0DUN'XSOLFDWHV¶'XSOLFDWHUHDGVDUHthe result of library amplification and
should not be considered as independent evidence supporting a variant call. Additionally,
PCR-induced errors can easily propagate to subsequent duplicate reads causing spurious
SNPs.

Sample level. BAM files for each library were combined together to create a
master file FRQWDLQLQJDOO'%$-VHTXHQFHV)LQDOO\*$7.µ,QGHO5HDOLJQHU¶ZDVXVHG
to perform local realignment of reads around indels from the Mouse Genome Project
[172] as well as putative indels identified by GATK. Reads aligning on the edges of
indels in the reference genome often aligned with mismatches due to the fact that the
penalty for opening a gap is higher than that of incorporating a mismatch. Local
realignment of reads around indel removes spurious SNP calls due to this alignment
artifact.

Variant calling pipeline
SNPs and indels. *$7.µ8QLILHG*HQRW\SHU¶DQG6DPWRROV YHUVLRQ 
µPSLOHXS¶IXQFWLRQFRPELQHGZLWK%&)WRROVZHUHXVHGWRGLVFRYHU613VDQGVPDOOLQGHOV
in the variant call format (VCF). Reads with bitwise flag (0x704) that include reads
flagged as 1) duplicates (0x0400), 2) failed QC (0x0200), 3) non-primary alignment
(0x0100), and 4) unmapped (0x0004) were not considered for variant calling. GATK
µ8QLILHG*HQRW\SHU¶ZDVXVHGZLWKWKHSDUDPHWHUVµ-bfh 4000 -rbs 1000000 -dcov 500 -heterozygosity .0001 --genotype_likeliKRRGVBPRGHO%27+¶6DPWRROVµPSLOHXS¶ZDV
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XVHGZLWKWKHSDUDPHWHUVµ-C 50 -d 1000 -E -Q 20 -T¶IROORZHGE\%&)WRROVZLWK
default parameters. We only selected variants that were jointly identified by GATK and
SAMtools

Structural variants. Structural variants were identified using three different
approaches including split-read, discordant read pairs, and uneven distribution in the read
depth.
Split-read. Pindel (version 0.2.4) [178] ZDVXVHGZLWKWKHSDUDPHWHUVµ-v 500¶DQG
µSLQGHOYFI¶ZDVXVHGWRJHQHUDWHYFIILOHV3LQGHOH[SORLWVUHDG-pairs where one read is
uniquely aligned and its mate read could only be aligned partially. The split-alignment of
the read indicates that it either overlaps deletion breakpoints or contains one end of an
insertion.

Discordant read pairs. BreakdancerMax (version 1.1) [179,180] was run with the
SDUDPHWHUVµǦc 3 Ǧm 10000000 Ǧq 25 Ǧr 3 Ǧh ±I¶WRGHWHFWLQVHUWLRQVGHOHWLRQVDQG
inversions. It uses anomalous read pairs that either do not align in concordance with the
library design or align considerably closer or farther than the expected insert sizes.

Uneven distribution of read depth. Copy Number Detector (CND, version 1.3)
[181] was run with the default settings. CND is exclusively designed to detect copy
number gains and losses in homozygous diploid organisms, such as inbred mouse strains.
It uses both the coverage of sequence reads, and the rate of apparent heterozygous SNPs
(paralogous sequence variants) to determine CNV gains and losses.

Variant filtering pipeline
In-house Python scripts were used to filter raw variant calls based on multiple
criteria. These filters removed low-quality variants due to alignment artifacts and
sequencing errors. They include number of reads supporting the variant, alignment
quality of reads supporting the variant, quality scores of variant calls by sequencer etc.
DBA/2J is a fully inbred strain and we therefore only retained homozygous SNPs and
indels. Structural variants that were supported by less than three libraries were removed.
Variant quality thresholds of 30 and 50 were used to filter Pindel and Breakdancer variant
calls respectively. We removed structural variants that overlapped low complexity
regions including centromere, telomere and assembly gaps in the reference genome. The
genomic coordinates of these regions were obtained from the UCSC Table browser [182]
(mm10). Python scripts along with the default filtering parameters that were used to filter
raw variants calls from various variant detection tools including GATK, Samtools, Pindel
and BreakDancerMax can be downloaded here:
https://github.com/ashutoshkpandey/Variants_call
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Variant annotation pipeline
We used SnpEff [183] to perform functional annotation of SNPs and indels, and
categorize them into nonsense, splice-site, frameshift and missense SNPs. The annotation
was performed against mouse gene models from Ensemble (version 69) and RefSeq
(downloaded in October 2012). An in-house Python script
(https://github.com/ashutoshkpandey/Annotation/blob/master/Grantham_score_calculator
.py) was used to generate Grantham scores to predict the impact of the amino acid
substitution due to missense mutation. Missense variants categorL]HGDVµUDGLFDO¶DQG
µPRGHUDWHO\UDGLFDO¶ZHUHGHILQHGDVGHOHWHULRXV:HDOVRXVHG3RO\3KHQ-2 (version
2.2.2) [184] with default HumDiv model to predict the impact of the amino acid
substitution. Mouse annotation and sequence database for Polyphen-2 were prepared by
downloading mouse Uniprot (version 2012_11) [185] and PFAM (downloaded in
November 2012) [186]. Missense variants predicted to be 'probably damaging' or
'possibly damaging' were defined as deleterious.

Experimental validation for variants
SNPs and indels were selected for validation by traditional Sanger sequencing.
Primers were designed using Primer3 (http://frodo.wi.mit.ed/primer3/). PCR assays were
performed using 5 ng DBA/2J genomic DNA, 10 pmol each of forward and reverse
primer in 50 μl. The following cycle parameters were used: 95 °C for 4 min, 35 cycles of
95 °C for 30 s, 55 °C for 30 s and 72 °C for 1 min, and 72 °C for 5 min. PCR products
were purified with 2 μL ExoSAP±IT (Invitrogen Corporation). Sanger sequencing was
performed using an ABI 3730.

RESULTS

Whole genome sequencing and alignment
The DBA/2J mouse genome was sequenced to a depth of 90-fold coverage by the
Illumina HiSeq 2000 sequencing platform. 14 paired-end libraries with different insertsizes ranging between 150-600 nt were sequenced to generate 4.08 billion reads (374
billion nucleotides). The sequencing reads were aligned against the GRCm38 reference
genome (mm10), followed by base recalibration, flagging of duplicates reads and local
realignment of reads around indels (Figure 2-2). A total of 3.56 billion reads were
aligned onto the reference genome, and 92% of the aligned reads were properly paired.
:HGHILQHGµDFFHVVLEOHUHIHUHQFHJHQRPH¶DVIUDFWLRQRIWKHUHIHUHQFHJHQRPHH[FOXGLQJ
gaps and regions of low complexity (ambiguous read alignment). Around 90% and 80%
RIWKHµDFFHVVLEOHJHQRPH¶KDVFRYHUDJHRIDQGUHDGVSHUEDVHUHVSHFWLYHO\2YHU
22 percent of the total aligned reads were not considered towards coverage analysis
because they belonged to one of the following categories: PCR duplicates, reads with low
base quality, and reads with low mapping quality.
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Figure 2-2.

Variant discovery workflow

Notes. Sequence data is organized and processed at three levels including raw read data
for each sequencing lane, aligned reads for each library, and combined reads for each
sample. The first step involves quality control assessment, alignment to the GRCm38
reference genome (mm10), and post-processing of the aligned data. In the second step,
the combined aligned data is used to identify SNPs, indels, and structural variations,
which are further quality filtered and functionally annotated.
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Detection and distribution of SNPs and indels
We generated a catalogue of over 5.4 m high confidence sequence variants
(Figure 2-3) including 4.46 m single nucleotide polymorphisms (SNPs) and 0.94 m
insertions and deletions (indels). On average, there is one sequence variant present for
every 500 bases in the reference genome. The ratio of transitions to transversions is 2.1:1
(3.02 m/1.44 m) which is strikingly similar to that observed in recent human studies
particularly from the 1000 Genomes Project [2]. This indicates that majority of genetic
variation between the two strains are spontaneous and neutral in nature. Indels are
distributed evenly with respect to the parental genomes and the ratio of insertions (0.45
m) to deletions (0.49 m) is close to 1.
We assigned functional consequences to the sequence variants against RefSeq
gene models. As expected, over sixty-percent (3.25 m) of variants including SNPs and
indels are located in intergenic regions. A total of 1.77 m SNPs are located within genes,
including introns (92.00%), exons (2.22%), 3' UTRs (1.74%), and 5' UTRs (0.30%).
Approximately 32k and 34k SNPs are located within 2Kb of flanking region upstream
and downstream of genes. Similarly, a total of 0.38 m indels are located within genes,
including introns (93.20%), exons (0.39%), 3' UTRs (2.03%) and 5' UTRs (0.22%). 7.8k
and 8k indels are located within upstream and downstream regions. The ~0.45 m
insertions range in size from 1 bp to 33 bp and ~0.49 million deletions range in size from
1 bp to 55 bp. As expected, small indels are more frequent than large indels. The majority
of small indels±65 % of the all insertions and 70% of all deletions²are 1 to 3 bp in
length. Point indels account for 45% of insertions and 41% of deletions (Figure 2-4).
Variant density varies greatly across the genome (Figure 2-3). For example, a
distal region of chromosome 1 from 170 Mb to 176 Mb known to be enriched for a
number of behavioral and expression quantitative trait loci (QTLs) [187] has a high
divergence rate (~5000 variants/Mb), whereas a 35 Mb region from 31 Mb to 66 Mb in
the middle of chromosome 10 has a very low divergence (~30 variants/Mb). The
unevenness in variant distribution can be attributed to complex history of the laboratory
strains and the retention of long intervals that are almost identical by descent [188,189].

Functional consequences of coding SNPs and indels

Missense variants. We identified 39,268 exonic SNPs including 32,871 SNPs
that are located in protein-coding genes. Of 32,871 coding SNPs, 21,976 are synonymous
whereas 10,895 are nonsynonymous (missense, Supplementary Table 2-1). These
10,895 missense SNPs are located in 4,271 protein-coding genes. A total of 2,073 aminoacid substitutions (19.0% of missense SNPs) have potentially deleterious effects on
function of 1,401 proteins based on analysis by PolyPhen2. Similarly, 1,760 substitutions
(16.15%) have potentially deleterious effects on function of 1,275 proteins based on
Grantham matrix scores. Five hundred and eighty five substitutions in 502 proteins are
jointly identified to be deleterious. Proteins in the joint set are enriched for gene
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Figure 2-3. Distribution and density of sequence and structural variants along the
DBA/2J genome
Notes. Moving inward from the outer circle, arcs in circle 1 denote chromosomes. Circle
2, SNP density with 100kb window (black is the lowest density and orange is the highest
density). Circle 3, Indels density with 100kb window. Circle 4, Structural variants. Circle
5, CNVs, blue (outward) denotes loss of CNVs and green (inward) denotes gain of
CNVs.
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Figure 2-4.

Distribution of indel lengths

Notes. The X-axis represents size of the indel and the Y-axis represents number of indels
in thousands. Indels only up to 50 bp in length were considered for this analysis. As
expected, the frequency of indels decreases with length.
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ontology (GO) terms including sensory perception of chemical stimulus, olfactory
receptor activity and neurological system process (Benjamini p < 10-5). A large subset
(20%) of the joint set includes olfactory, taste, and vomeronasal receptors.

Nonsense variants. We identified 66 SNPs, including 50 stop gains and 16 stop
losses that affect a total of 63 genes. On manual inspection, we excluded five of these
SNPs as nonsense variants due to ambiguous gene models and annotation error.
Therefore, the final number of nonsense SNPs is 61, including 47 stop gains and 14 stop
losses that affect a total of 58 genes (Supplementary Table 2-1). Forty-percent (n=25)
of nonsense mutations result in protein variants with less than 10 % length differences
compared to the reference protein. Eleven only differ by one to four amino acids in
length. We also predicted that 33 nonsense mutations would produce truncated transcripts
and 28 nonsense mutations would result in nonsense-mediated decay of the variant
transcripts. We detected the two known nonsense mutations in Gpnmb [144] and Ahr
[190]. DBA/2J is the only mouse strain out of 29 mouse strains (Mouse Genomes Project
[172]) that has acquired a premature stop codon (CGA to TGA, rs47598337) in exon 4 of
thirteen exons long Gpnmb resulting in a truncated transcript that presumably undergoes
nonsense mediated decay. Expression variation in Gpnmb maps significantly to the
location of the gene itself (Figure 2-5a). The nonsense variant in Gpnmb is a major
contributing cause of pigment dispersion type glaucoma in DBA/2J [144].

Splice-site variants. We identified 242 SNPs and indels that changed conserved
bases at splice sites. We manually examined these variants and affected genes, and
excluded 46 of these variants due to non-coding gene types and incorrect gene models.
The final number of splice-site variants is 196 affecting 191 genes (Supplementary
Table 2-1). An example is a C to T mutation (rs30117984) in the acceptor site of C-type
lectin domain family 7 member A gene (Clec7a). Expression variation in Clec7a maps
significantly to the location of the gene itself (Figure 2-5b). This splice site variant has
been associated with susceptibility to infection with Coccidioides species [191].

Frameshifts and inframe indels. 735 small insertions and 770 small deletions
are located within exons. Of these, 453 including 209 insertions and 244 deletions are
located in protein-coding genes. Indels in coding sequence can be highly disruptive,
especially when they introduce frameshift mutations resulting in abnormally short or
abnormally long altered polypeptides. A subset of 99 small coding indels including 44
insertions and 55 deletions in 98 genes are predicted to result in frame shift mutations
(Supplementary Table 2-1). An example is 'TA' deletion (rs241579076) in the
hemolytic complement gene (Hc; chromosome 2 at 35.043208 Mb), that is associated
with susceptibility to allergen- induced bronchial hyper-responsiveness [192] and
intensified neurodegenerative responses [193]. Expression variation in Hc maps
significantly to the location of the gene itself (Figure 2-5c).
The small coding indels are enriched in trinucleotides (multiples of three), which
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Figure 2-5.

Linkage maps of eQTLs for DBA/2J variants

Notes. (a) Gpnmb expression in eye is controlled by a cis eQTL with a peak LOD score
of 7 located on Chr 6 at 48.9 Mb. This location corresponds precisely to the location of
the Gpnmb gene (solid triangle). The horizontal lines provide genome-wide significance
thresholds for the QTL determined by permutation analysis (upper <.05 and lower <.63)
(b) Clec7a expression in spleen is controlled by a cis eQTL with a peak LOD score of
17.89 located on Chr 6 at 128.46 Mb (c) Hc expression in lung is controlled by a cis
eQTL with a peak LOD score of 16.91 located on Chr 2 at 33.30 Mb (d) Combined
eQTL mapping of Glo1, Btbd9 and Dnahc8 mRNAs in hippocampus. The eigenvalues
associated with the first principal component maps with a LOD of ~28 to a CNV gain
region spanning the above three genes in DBA/2J genome. Expression data used here
were generated in GeneNetwork (www.genenetwork.org) using (a) BXD Eye M430v2
(Sep08) RMA Database, (b) UTHSC Affy MoGene 1.0 ST Spleen (Dec10) RMA Exon
Level Database, (c) HZI Lung M430v2 (Apr08) RMA Database and (d) UMUTAffy
Hippocampus Exon (Feb09).
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account for 78% (n=354) of total exonic indels including 165 insertions and 189 deletions
(Figure 2-6, Supplementary Table 2-1). The trinucleotide indels are functionally not as
severe as frameshift variants but they can still have a high functional impact on the
structure and function of the protein. An example is an inframe deletion (rs220745914,
FKU0E RIµ*$7*7*¶QXFOHRWLGHVLQWKH Cd44 gene that deletes two
amino acids.

Functional consequences of non-coding SNPs and indels
The vast majority of sequence variants are non-exonic and a particularly
interesting subset of these non-coding variants may modulate transcription [194].
Sequence variants in the cis regulatory elements, including transcription factor binding
sites, enhancers and ¶875microRNA binding sites affect gene expression. Recently,
the mouse Encyclopedia of DNA Elements (ENCODE) consortium
(http://www.nature.com/encode website) generated and published a plethora of sequence
data that explores the genomic landscape of such elements in diverse mouse tissues [195].
Over 80% of 5.4 m variants had no potential functional impact based on mouse
ENCODE data, but the remaining 20% (0.93 m) variants potentially affect one or more
cis acting elements. Around 3% of them affect DNase I hypersensitive regions that mark
open chromatin. ~15% of variants affect histone modifications including H3K36me3,
H3K4me1, H3K4me2, H3K4me3 (active enhancers) and H3K27me3, H3K9me3, and
+.PH LQDFWLYHRUSRLVHGHQKDQFHUVLWHV :HDOVRVFDQQHG¶875VRIP51$VIRU
variants in microRNA target sites. microRNA play a vital role in the regulation of gene
expression by either translation inhibition or transcript degradation [196]. Three hundred
and fifty variants disrupt 284 microRNA binding or target sites. Additionally, 36 variants
are located within 31 mature microRNA coding sites in the microRNA primary
transcripts.

Functional consequences of large structural variants
To identify structural variants, we used a combination of three different
approaches including anomalous read-pairs, split-read and non-uniform read depth.

Split read approach. Pindel exploits reads with split alignment to identify exact
breakpoints of the SVs. We detected ~2,919 insertions and ~14,486 deletions. The
insertions range from over 50 bp to 31 kb and deletions range from over 50 bp to 32 kb.
One hundred and eighty three indels affect exons or UTRs in 148 genes (Supplementary
Table 2-2). An example is a 230 nucleotides deletion (chr16:18.407299-18.407528) in
WKH¶875RIFatechol-O-methyltransferase (Comt). This deletion variant has been
associated with differences in the expression of genes involved in glutamatergic and
GABAergic systems [88]. Additionally, it has also been associated with higher order
phenotypes including sensitivity to dopamine receptors antagonist haloperidol and
chloradiazepoxide, an allosteric modulator of GABA-A receptors [88].
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Figure 2-6.

Distribution of lengths of coding indels

Notes. The X-axis represents size of the indel and the Y-axis represents number of indels.
As expected, the coding indels are enriched in trinucleotides (multiples of three) that
GRQ¶WUHVXOWLQIUDPHVKLIWYDULDQWV
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Anomalous read-pairs. BreakDancerMax exploits read pairs with highly deviant
insert sizes to identify SVs. We detected ~5,147 insertions and 28,025 deletions. The
insertions range from over 100 bp to 0.5 kb and deletions range from over 100 bp to 976
kb. Five hundred and one indels affect exons or UTRs of 340 genes (Supplementary
Table 2-2). An example is 0.66 Mb deletion (chr6:89.678881-90.331580) of large set of
16 vomeronasal receptors (V1r) in the DBA/2J genome. Deficient pheromone responses
in mice have been associated with a significant reduction of male to male and maternal
aggressiveness compared to controls [197].

Read depth. CND exploits genomic regions with highly deviant read depth or
coverage to identify copy number variants (CNVs). We detected 7,615 CNVs, including
6,189 gains and 1,426 losses. Gains and losses have an average length of 3.3 kb and 4.3
kb respectively. Gains range from over 2 kb to 177 kb, and losses range from over 2 kb to
343 kb. A vast majority of copy number variants (~70%) affect intergenic regions. Of
copy number gains relative to the C57BL/6J genome, 157 cover 215 genes completely
(Supplementary Table 2-2). Of the losses, 40 cover 54 genes completely. An example is
a copy number gain variant (chr17:30.443984-30.928714 Mb) that duplicates three genes
entirely, including glyxolase 1 (Glo1), BTB domain containing 9 (Btbd9), and dynein
axonemal heavy chain 8 (Dnahc8) in DBA/2J. Expression variation in these genes maps
significantly to the location of the CNV (Figure 2-5d). The increased expression of Glo1
in brain due to the CNV has been associated with anxiety-like behavior in mice
[198,199]. GO enrichment analysis of the 269 that have been deleted or duplicated in
their entirety revealed a significant enrichment (Benjamini-Hochberg P <0.01) of genes
DVVRFLDWHGZLWKµ0+&SURWHLQFRPSOH[¶DQGµLPPXQHUHVSRQVH¶$ODUJHVXEVHW a 
of these genes includes major histocompatibility complex genes (H2), killer cell lectinlike receptors (Klra), and genes associated with sensory perception including olfactory
and vomeronasal receptors.

DBA/2J private variants
To obtain a list of private DBA/2J SNPs and indels, we compared DBA2/J
variants with variant calls from 17 diverse strains of mice that were sequenced as a part
of the Mouse Genome Project [172]. We classify a variant as private to DBA/2J only if
all the other strains carry homozygous reference alleles at the variant site. We identified
69,554 private SNPs and 32,176 private indels in DBA/2J. They contribute to 1.5% and
3.42% of the total number of SNPs and indels in DBA/2J. Nearly half of the private SNPs
(49%) and indels (46%) are located within intergenic regions. Three hundred and seventy
three of the private SNPs result in non-synonymous mutations in 255 genes. Six private
SNPs result in premature stop codon including 2310035K24Rik, Gm5592, Gpnmb,
Klk1b8, Nbeal2, and Zfp277. Six private indels introduce frameshift variants including
4930523C07Rik, Adam33, Caln1, Kif17, Tgif2, and Zfp354a.
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False positive rate detection
We resequenced 30 nonsense variants and 62 randomly selected missense variants
using traditional Sanger sequencing to assess the false positive rates (FPR) of variants.
We validated 27 nonsense variants and 60 missense variants²an FPR of 10% and 3.23%
respectively. We also resequenced 20 splice-site variants and all of them were confirmed
as true variants. We resequenced 13 frameshift variants and 11 of them were validated,
indicating a false positive rate of 15.38%. Finally, we performed PCR-based validation of
40 predicted large structural variants. A total of 32 indels were validated, a ~20% false
positive rate for detecting large indels.

DISCUSSION
The goal of this work has been to identify sequence and structural variants
between the parental strains of the BXD family. To achieve this goal, we analyzed the
DBA/2J genome at ~90X coverage using Illumina sequencing platform. We identified
~4.46 million SNPs, ~0.94 million indels, and ~20,000 high confidence SVs. The
comprehensive catalog of sequence and structural variants that we uncovered provides an
unprecedented resource with which to study the functional impact of naturally occurring
sequence variants in a remarkably large and stable set of BXD lines. An interesting
subset of high-impact functional variants can be utilized to initiate genome-wide reverse
genetic analysis of complex traits such as PheWAS. Variant calls including SNPs, indels
and SVs are available via a mirror of the UCSC genome browser
(ucscbrowserbeta.genenetwork.org).
The genome of the DBA/2J strain has already been sequenced twice at lower
coverage, initially by Celera Genomics [200] at about 1.3X using conventional Sanger
sequencing, and by Mouse Genomes project (MGP) [172] at about 23X using almost
precisely the same short read technology we have exploited. For this study, we combined
sequence data from the MGP with our short-read data to enhance the sequence coverage.
We compared high-confidence variant calls from our analysis with DBA/2J variant calls
from the MGP [172]. We found an overlap of 4,621,903 variants including 4,056,910
SNPs and 564,993 indels (Figure 2-7). Of non-overlapping variants 941,379 and 487,796
were exclusively identified by our analysis and MGP respectively. We recalled 90% of
SNPs and 87% of the indel calls from the MGP. We also added 469,212 novel SNPs
including 1,297 non-synonymous SNPs and 472,167 novel indels. Our analysis
substantially increased the number of known indels from 0.63 m to 1.1 m. This was
expected as we used higher sequence coverage (100x vs. 50x) and longer reads (100 nt
vs. 50 nt) compared to the MGP project. Longer reads generate more variant calls with
higher acuracy [201] due to their higher alignability and mapping quality especially in
low complexity regions. Longer reads also allow bigger gaps during alignments and are
therefore more efficient in detecting relatively larger indels. Similar observations were
made when raw (unfiltered) variant calls including high and low confidence variants were
compared.
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Figure 2-7.
MGP

Comparison of DBA/2J variant calls between our data (UTHSC) and

Note. The left and the right Venn diagrams compare filtered SNPs and indels
respectively.
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CHAPTER 3.

GENOMIC ANALYSIS OF ALLELE-SPECIFIC EXPRESSION
IN THE MOUSE LIVER

SYNOPSIS
Genetic differences in gene expression contribute significantly to phenotypic
diversity and differences in disease susceptibility. In fact, the great majority of causal
variants highlighted by genome-wide association are in non-coding regions that modulate
expression. In order to quantify the extent of allelic differences in expression, we
analyzed liver transcriptomes of isogenic F1 hybrid mice. Allele-specific expression
(ASE) effects are pervasive and are detected in over 50% of assayed genes. Genes with
strong ASE do not differ from those with no ASE with respect to their length or promoter
complexity. However, they have a higher density of sequence variants, higher functional
redundancy, and lower evolutionary conservation compared to genes with no ASE. Fifty
percent of genes with no ASE are categorized as house-keeping genes. In contrast, the
high ASE set may be critical in phenotype canalization. There is significant overlap
between genes that exhibit ASE and those that exhibit strong cis expression quantitative
trait loci (cis eQTLs) identified using large genetic expression data sets. Eighty percent of
genes with cis eQTLs also have strong ASE effects. Conversely, 40% of genes with ASE
effects are associated with strong cis eQTLs. Cis-acting variation detected at the protein
level is also detected at the transcript level, but the converse is not true. ASE is a highly
sensitive and direct method to quantify cis-acting variation in gene expression and
complements and extends classic cis eQTL analysis. ASE differences can be combined
with coding variants to produce a key resource of functional variants for precision
medicine and genome-to-phenome mapping.

INTRODUCTION
Genetic variation contributes greatly to phenotypic diversity and differences in
disease susceptibility by altering the structure and expression levels of proteins. The
analysis of complex phenotypes in the pre-genomic era focused on coding variants,
especially including nonsense, missense, and frameshift mutations. However genomewide association studies conducted over the last decade have demonstrated that a great
majority (>90%) of trait/disease-associated variants are located in non-coding regions.
These non-coding variants primarily act by modulating gene expression, and they are the
major cause of variation in susceptibility to complex diseases [94-96].
Sequence variants that affect gene expression can act in cis or in trans. Cis-acting
variants represent first-order local control of gene expression that is specific to each
individual haplotype. For example, sequence variants in transcription factor binding sites
may affect expression of cognate genes on the same chromosome. Cis-acting variants are
key to understanding heritable variation in disease risk, and serve as direct targets for
diagnosis and treatment of diseases. Cis-acting variants can, of course, also have secondorder distal or trans effects. A small subset of cis-modulated transcripts consists of
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master trans-regulators (for example, transcription factors, miRNAs) that control the
abundance of large numbers of downstream target genes on both sets of chromosomes.
Hence, identification of cis-modulated transcripts serves as an key molecular resource for
reverse genetics studies that focus on downstream consequences of altered expression.
Currently, two genome-wide approaches can be employed to identify cis-acting
variation in expression. The first approach, known as expression quantitative trait locus
(eQTL) mapping, performs classical genetic linkage analysis of expression usually for an
entire transcriptome or proteome. This approach has been widely applied to study the
effects of segregating variation on gene expression in yeast, mice, maize, and humans
[97,142,202-204]. The largest study to date is the ongoing Genotype-Tissue Expression
(GTEx) project that is generating a comprehensive resource of cis eQTLs for multiple
tissues in a large human cohort [205,206]. The second approach, widely used in studies
of model organisms, exploits rtPCR or RNA-seq to assay allele-specific expression
(ASE) differences in isogenic heterozygous (F1) individuals [207-211]. RNA-seq can
reliably distinguish mRNAs transcribed from the alternative alleles, and can be used to
detect unequal production of the two alleles. A major advantage of isogenic F1 hybrids is
that they provide a way to control for environmental and trans-acting influences. Both
alleles are present within an identical environment and subjected to the same genetic
background and regulatory networks. As a result, any expression differences between
alleles in an isogenic F1 can be confidently attributed to genetic or epigenetic regulatory
variant acting in cis [212-214].
In this study we evaluate and compare the impact of cis-acting variation on
expression in murine liver using both ASE and eQTL approaches. We exploit RNA-seq
data from isogenic F1 hybrids and array data from a large set of recombinant inbred
strains of mice²the BXD cohort, and generate a molecular resource for genome-wide
reverse genetics that focuses on downstream consequences of altered gene expression
[88,171]. We address the following questions:
x
x

x

How do genes that exhibit ASE differ from those that do not?
How do the two approaches highlighted above compare in terms of
detecting effects of local polymorphisms on expression? More
specifically, are cis-modulated transcripts identified by eQTL mapping
also consistently detected by ASE analysis?
How frequently do cis-acting variants that cause mRNA differences also
cause differences in protein expression?

MATERIALS AND METHODS

RNAseq data for C57BL/6JxDBA/2J hybrids
We downloaded paired-end RNA-seq data from the European Nucleotide Archive
(accession number ERP000591) for liver of C57BL/6JxDBA/2J F1 female hybrids
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generated by crossing C57BL/6J females with DBA/2J males [172]. The data consist of
transcriptome sequence from six biological replicates. We acquired a total of ~181 m
read pairs (2x76 nt in length). We removed low quality reads and used the remaining
~173 m read pairs for alignment.

RNA-seq read alignment
We aligned RNA-seq reads to both the C57BL/6J reference genome (mm10
DVVHPEO\ DQGWKH'%$-JHQRPHXVLQJ³6SOLFH7UDQVFULSWV$OLJQPHQWWRD5HIHUHQFH´
tool (STAR, version 2.3.1a) [215] ZLWKWKHIROORZLQJSDUDPHWHUV³-outFilterMultimapNmax 10 --RXW)LOWHU0LVPDWFK1PD[´5HDGSDLUVWKDWZHUHQRW
aligned in concordance with the library design, in particular read strand, were removed.
We allowed a maximum insert size of 300,000 nucleotides (maximum intron length) to
allow alignment of those read-pairs aligned to different exons. We selected read pairs for
which both reads were uniquely aligned and for which each had less than six mismatches.
If one member of a read-pair could not be aligned then we retained the other member
only if it could be aligned uniquely.

Calculation of allelic ratio
:HXVHG6$0WRROV YHUVLRQ ³SLOHXS´IXQFWLRQ[176] and an in-house
Python
(https://github.com/ashutoshkpandey/ASE_prealignment/blob/master/Allele_specific_SA
M.py) script to assign reads to their parental allelic origin by comparing alignments to the
C57BL/6J and the SNP-substituted DBA/2J genome. If reads were aligned to both
genomes then we required them to map at the same locations. Those reads that
overlapped SNPs were assigned to their parental allele origin. To ensure that differential
expression was not due to amplification by PCR during library preparation, we removed
all potential PCR duplicates except for the single read with the fewest mismatches using
3LFDUG¶V0DUN'uplicates tool (version 1.78). We calculated allelic ratios for each SNP
defined as the ratio of number of reads assigned to the reference allele (B) to the total
number of aligned reads (B+D).

Definition of ASE using chi-square test
For each SNP we used an interquartile range (IQR) method to identify outlier
allelic ratios from the set of F1 replicates. Outlier ratios were located outside the [Q1 ±
1.5(IQR) and Q3 + 1.5(IQR)] range where Q1 and Q3 represent first and third quartiles
and IQR is calculated as Q3 ± Q1. Reads from replicates showing concordant allelic
ratios were merged and allelic ratios were recalculated. We used the chi-square goodness
of fit test to determine allelic imbalances for a given SNP. For a SNP showing an allelic
imbalance, the ratio will deviate from 0.5. We defined genes as having an allele-specific
expression difference if they contained one or more SNPs with an allelic imbalance at an
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FDR threshold of less than 0.1 [216]. We also required the expression fold difference to
be >1.25.

Array expression data and eQTL mapping
We used an Affymetrix data set (Mouse 430 v2.0 array) consisting of liver gene
expression data for 40 genetically diverse BXD strains (GeneNetwork.org accession
GN310,
http://genenetwork.org/webqtl/main.py?FormID=sharinginfo&GN_AccessionId=310).
We performed robust multichip analysis (RMA) preprocessing and rescaled values to
log2 and stabilized the variance across samples [217]. We used QTL Reaper, mapping
code that uses the method of Haley and Knott for eQTL analysis [218], and a set of 3,200
markers. We excluded probe sets located on X and Y chromosomes (~2,500 probe sets).
Locations of probe sets were identified using custom annotation files. Similarly, we
performed pQTL mapping on expression data from 172 proteins [219]. This data can be
downloaded from Genenetwork.org (accession GN490,
http://www.genenetwork.org/webqtl/main.py?FormID=sharinginfo&GN_AccessionId=4
90). To identify Affymetrix probes that overlapped sequence variants, we first aligned
probe sequences against the mouse reference genome (mm10) using BLAT [220], and
then compared genomic coordinates of probes for overlap with sequence variants.

Comparison between ASE and non-ASE genes (URLs)
We downloaded the liver-specific regulatory elements data from Ensembl
Regulatory build (ftp://ftp.ensembl.org/pub/release-81/regulation/mus_musculus); see
more details on this build here:
http://www.ensembl.org/info/genome/funcgen/regulation_sources.html. For TFBS
comparison we used data from MotifMap²genome-wide maps of regulatory elements.
The file was downloaded using the following link:
(http://www.igb.uci.edu/~motifmap/motifmap/MOUSE/mm9/multiz30way/MotifMap_M
OUSE_mm9.multiz30way.tsv.bz2). A list of house-keeping genes was downloaded using
the following link: http://www.tau.ac.il/~elieis/HKG. In order to compare for the
evolutionary conservation between the ASE and non-ASE genes, we used GERP++
scores for mouse
(http://mendel.stanford.edu/SidowLab/downloads/gerp/mm9.GERP_elements.tar.gz). We
downloaded M. musculus and H. sapiens paralog data from Ensembl BioMart
(www.ensembl.org/info/data/biomart.html) [221,222]. All the mm9 coordinates were
converted to mm10 using UCSC liftOver utility. The counts/scores of cis-regulatory
elements, TFBSs, DBA/2J sequence variants, and GERP++ scores were normalized by
gene length before comparison.
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Single marker analysis
We performed single marker analysis as an alternative to eQTL mapping to
identify cis-modulation in expression. For each gene we selected its closest marker and
classified BXDs by genotype (B allele or D allele) for that marker. We compared
expression using a t-test and selected genes showing significant expression difference at
an FDR of < 0.1.

RESULTS

DBA/2J specific reference genome
We substituted ~4.5 million DBA/2J SNPs (Chapter 1) into the reference genome
(GRCm38/mm10) to create a customized DBA/2J genome for RNA-seq read alignment.
A total of ~1.7 m SNPs are located within coding genes based on RefSeq annotation,
including introns (95.59%), exons (2.30%), 3' UTRs (1.80%) and 5' UTRs (0.30%).
These SNPs are distributed among 14,591 genes. SNPs in transcribed regions were used
to discriminate between, and identify, the parental allelic origin (B vs D) of transcripts in
isogenic F1 hybrids.

Haplotype-aware alignment corrects for allelic bias in read alignment
We downloaded paired-end liver RNA-seq reads for six biological replicates of
C57BL/6JxDBA/2J F1 females. We adopted a haplotype-aware alignment approach and
aligned ~350 m (~175 m paired-end) reads against both the B and the customized D
genomes (Methods). We used a SNP-directed approach to identify the allelic origin (B or
D) of reads that aligned over heterozygous SNPs in the F1 samples. Only uniquely
aligned reads were assigned to parental alleles. Approximately 0.27 m SNPs within genes
(a great majority within exons) had at least one read.
RNA-seq read alignment suffers from allelic bias that disfavors reads containing
sequence variants relative to the reference genome [223,224]. This bias generates lower
read counts for non-reference alleles, and overestimates ASE differences. To evaluate
bias, we examined allelic ratios²defined as the number of reads with the reference allele
(B) divided by the total number of reads (B+D). In the absence of bias, this ratio will have
a symmetrical distribution and a mean of 0.5. For each of the F1 samples, ratios were
well balanced, with nearly equal numbers of SNPs with high B or high D expression.
Additionally, mean and median ratios were close to 0.5 indicating that the majority of
SNPs exhibit small or undetectable ASE. We compared our results with a traditional
approach involving alignment of reads against the reference genome and allowing for
fewer mismatches (1 mismatch per 25 nt). This produced an artifactually high number of
SNPs with high B expression (~ 3,000 B vs ~400 D, two-sided binomial p < 10-323)
compared to the dual genome alignment (~2,325 B vs ~ 2,300 D, two-sided binomial p
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value = 0.724, Figure 3-1a, b). The mean and median of allelic ratios using the standard
approach were also skewed²0.69 (high B) and 0.68, respectively. This illustrates that the
haplotype-aware alignment workflow is highly effective in reducing allelic bias due to
read alignment.

High correlation of allelic ratios across biological replicates
:HFDOFXODWHGWKHFRUUHODWLRQRIDOOHOLFUDWLRVZLWKUHDGGHSWKDFURVVDOO
biological replicates. Allelic ratios were highly correlated with an average Pearson
correlation of 0.70 ± 0.02 for all pairs of replicates (n = 15). We merged data from
biological replicates, but to minimize variation across replicates, we discarded reads from
replicate with highly discrepant ratio (Methods). More than 90% of SNPs had closely
matched ratios across four or more replicates and were retained for further analyses. We
also checked the concordance of the polarity of ASE measured by neighboring (<75
nucleotides) but independent SNPs. In the great majority of cases SNPs within the same
JHQRPLFIHDWXUH ¶875H[RQLQWURQDQG¶875 ZHUHKLJKO\FRQFRUGDQW2QO\136
(6%) of 2,234 genomic features contained SNPs with opposite ASE polarity and the great
PDMRULW\ZHUHLQ¶875V n  ¶875VXQGHUJRH[WHQVLYHDOWHUQDWLYHSURFHVVLQJ
[225,226], and SNPs with opposite ASE polarity probably represent alternative
polyadenylation sites [88]. The high correlation of allelic ratios across the replicates and
the high concordance in polarity again demonstrate the accuracy of the haplotype-aware
alignment workflow. SNPs located within copy number variants, large insertions and
deletions or in close vicinity (< 75 nucleotides) to an indel can generate inaccurate ASE
estimates due to alignment artifacts. As a result, these SNPs were removed from further
analysis. Additionally, to ensure independent sampling we considered only one SNP of a
SNP pair when SNPs were separated by less than 75 nucleotides. Of 21,166 SNPs with
UHDGFRYHUDJHa ,358) SNPs were removed for one of these reasons.
ASE differences in liver are common
We tested the null hypothesis of equal abundance of transcripts representing B
and D alleles in isogenic F1 hybrids using a Chi-square Goodness of fit test (FDR < 0.1,
Methods). On average we used ~650 reads per SNP to test for ASE. At a minimum
threshold of 30 reads per SNP, we were able to test 15,808 SNPs in 3,589 genes
(Supplementary Table 3-1). We detected significant ASE in 5,298 SNPs from 1,905
genes (Supplementary Table 3-1, Figure 3-2). Most of these SNPs are contained within
FRGLQJH[RQV  DQG¶875V  Supplementary Table 3-1). Seven percent are
in introns and may represent unannotated exons or transcripts with unspliced or retained
introns. We obtained comparable results when the minimum read threshold was increased
WR 613VLQJHQHV DQGZKHQWKH)'5WKUHVKROGZDVGHFUHDVHGWR
(4,774 significant SNPs in 1,482 genes). Fifty-two percent (2,773 B vs 2,525 D) of SNPs
have higher expression from the B allele. There is no difference in the distribution of
average effect sizes for significant ASE between alleles (Figure 3-3). Over half of the
SNPs with significant ASE differ by less than two fold; one-third differ two±four folds;
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Figure 3-1. Comparison of the allelic bias in read alignment between traditional
and haplotype-sensitive approach
Note. Distribution of allelic ratios in (a) traditional and (b) haplotype-sensitive alignment.
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Figure 3-2.

Distribution of cis-modulated genes in liver

Notes. The outermost circle represents chromosomes. Moving in, the second circle
represents a scatter plot of ~15,000 SNPs tested for ASE. The Y-axis represents the allelic
ratio. SNPs with significant ASE are shown in red and blue, representing high expression
of the B and the D allele respectively. SNPs with insignificant ASE are shown in green.
These SNPs are located on or near the line representing an allelic ratio of 0.5. The third
circle represents a scatter plot of ~40,000 microarray probe sets tested for cis eQTLs. The
Y-axis represents the LOD scores of probe sets measured at the nearest marker (cis LOD).
Cis /2'  VFRUHVDVVRFLDWHGZLWKKLJKH[SUHVVLRQRIWKHB and the D allele are shown
in red and blue respectively. Cis LOD scores of less than 3 are shown in green. The
innermost circle represents a scatter plot of ~200 proteins tested for cis pQTLs. The Yaxis represents the LOD scores of proteins measured at the nearest marker (cis LOD).
Chromosomes X and Y were excluded.
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Figure 3-3.

Distribution of significant allelic ratios

Notes. 7KHOHIWER[SORWODEHOOHGDV³B>D´UHSUHVHQWV613VZLWKKLJKH[SUHVVLRQRIWKHB
allele (left Y-axis). The right boxplot represents SNPs with high expression of the D allele
(right Y-axis). The Y-axis represents allelic ratios. Outliers are not shown.
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and the remaining one-sixth differ more than four-fold. We detected the known low D
allele expression of aryl hydrocarbon receptor (Ahr)²a transcription factor that controls
xenobiotic metabolizing enzymes such as cytochrome P450 gene family [227]. Similarly
we also detected the known low B allele expression of alkaline phosphatase (Alpl)²a
gene linked to hypophosphatasia [86].

Comparison between ASE and non-ASE genes
Genes with high or low levels of ASE may differ in length, complexity of
promoters, sequence variant density, or evolutionary history. To explore these differences
we selected a subset of 418 genes with very high ASE ratios (>1.5 fold) and a subset of
465 genes with low or no ASE. All genes in both groups were required to have at least
two independent SNPs that supported their categorization. We also required all SNPs to
have more than 100 supporting reads²roughly the top ten percentile. The average read
depth for ASE and non ASE SNPs were 258 ± 180 and 262 ± 168. We defined each gene
DVWKHUHJLRQEHWZHHQWKHWUDQVFULSWLRQVWDUWVLWHDQG¶875ZLWKNERIIODQNLQJUHJLRQV
upstream and downstream. ASE genes do not differ from non-ASE genes in terms of total
JHQHOHQJWKRUWKHLU¶RU¶875OHQJWK Table 3-1). They also do not differ in numbers
of protein-coding transcripts (isoforms) or numbers of exons per transcript (Table 3-1).
However, ASE genes have a higher functional redundancy (number of paralogs)
compared to non-ASE genes (1.5 fold, p < 10-4, Table 3-1).
We also compared promoter complexity. There are no differences in the density
of liver-specific cis-regulatory elements defined using mouse ENCODE data [228].
Similarly, there are no differences in the density of transcription factor binding sites
defined using a comparative genomic approach [229] (Table 3-1). However, the subset of
genes with no or low ASE are enriched (p < 10-46, hypergeometric test) in housekeeping
genes [230]. In fact, nearly 50% of the non-ASE set are house-keeping genes. In contrast
only 20% of the ASE set belong to this category.
Another distinguishing characteristic of the two sets is their density of sequence
variants. The mean density in the non-ASE set is significantly different from the ASE set
(4.59 ± 0.02 versus 8.20 ± 0.25 per Kb, p ~ 0.0, two-tailed t test). This suggests that
genes in the non-ASE set are under comparatively stronger purifying selection.
To test whether ASE and non-ASE sets are subject to different levels of purifying
selection (the elimination of deleterious sequence variants) we compared the strength of
selective constraint (GERP++ scores) on genomic regions across 33 mammalian species
[125,126]. The ASE gene set (201.33 ± 10.85) have significantly lower conservation
scores than the non-ASE set (274.15 ± 13.26) indicating that they tolerate and accumulate
more mutations; a subset of which are highly likely to modulate expression (p < 10-4,
two-tailed t test, Table 3-1).
To evaluate if genes in ASE and non-ASE sets belong to different functional
categories, we compared them for overrepresented gene ontology and KEGG pathway
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Table 3-1.

Comparison between ASE and non ASE genes

Category
Gene length in Kilobase (Kb)
¶875OHQJWK .E
¶875OHQJWK .E
Coding transcripts per gene
Exons per transcript
Cis-regulatory elements (Kb)
Transcription factor binding sites (Kb)
Sequence variants (Kb)
Paralogs per gene
Conservation score (Kb)

ASE
58 ± 40
0.23 ± 0.03
1.80 ± 0.08
1.50 ± 0.05
12.40 ± 0.37
0.37 ± 0.01
1.61 ± 0.07
8.20 ± 0.25
5.31 ± 0.36
201.33 ± 10.8
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Non ASE
63 ± 30
0.25 ± 0.01
1.87 ± 0.06
1.65 ± 0.06
12.90 ± 0.29
0.34 ± 0.01
1.70 ± 0.07
4.59 ± 0.02
3.56 ± 0.22
274.15 ± 13.2

P-value
0.31
0.15
0.54
0.1
0.31
0.11
0.38
0.00000001
0.0000286
0.0000331

terms using DAVID functional annotation tool [231]. ASE genes are significantly
enriched (Benjamini corrected p < 0.05) in genes associated with KEGG pathway terms
LQFOXGLQJµFRPSOHPHQWDQGFRDJXODWLRQFDVFDGHV¶µUHWLQROPHWDEROLVP¶µPHWDEROLVPRI
[HQRELRWLFVE\F\WRFKURPH3¶DQGµOLSLGIDWW\ DFLGDQGVWHURLGPHWDEROLVP¶NonASE genes are enriched in genes with gene ontology (GO) terms representing broad
IXQFWLRQDOFDWHJRULHVVXFKDVµPDFURPROHFXOHORFDOL]DWLRQ¶µFDWDO\WLFDFWLYLW\¶DQG
µXELTXLWLQPHGLDWHGSURWHRO\VLV¶
To evaluate the effect of ASE on phenotypes we performed phenotype enrichment
analysis [232] on mouse-mutant phenotypes [233] derived from Mouse Genome
Informatics (MGI, www.informatics.jax.org/phenotypes.shtml). As noted above, ASE
genes compared to non-ASE genes are enriched (unadjusted p < 0.01) for phenotypes
LQFOXGLQJµDEQRUPDOJDOOEODGGHUSK\VLRORJ\¶ 03 µDEQRUPDO[HQRELRWLF
induced morbidLW\PRUWDOLW\¶ 03 DQGµDEQRUPDOJOXFRVHKRPHRVWDVLV¶
(MP:0002078).

Identification of cis eQTLs
We performed linkage-based eQTL mapping using a gene expression data set
generated using liver samples from 40 BXD strains (Methods). Of the ~45,000 probe
sets, we selected ~41,500 that have a uniquely assigned gene identifier. This subset
represents ~19,000 genes. Cis eQTLs were required to have LOD scores greater than 3
DQG/2'SHDNVZLWKLQ0ERIWKHLUFRJQDWHJHQH$/2'VFRUHURXJKO\
corresponds to a nominal p value of < 0.001 and is widely used to indicate a high
probability of linkage. We detected a total of 1,907 cis eQTLs corresponding to 1,474
genes (Supplementary Table 3-2). cis H47/VZLWKYHU\KLJK/2'VFRUHV  LQFOXGH
Snx6, Adi1, Cfh, Fbxo39, and St3gal4.

Variant overlapping probes cause spurious cis eQTLs
SNPs and indels in probe sequences can influence hybridization kinetics and
cause incorrect measurement of expression. Twenty-five percent of apparent cis eQTLs
detected in the hippocampus are probably caused by variants in probes rather than by
genuine differences in expression [207]. We identified 739 cis-modulated probe sets that
overlap D variants. To evaluate how these variants affect the direction and size of
additive effects for corresponding cis eQTLs, we compared cis eQTLs between probe
sets with variants and probe sets without variants. Probe sets without variants were
precisely balanced with respect to B versus D effects. In contrast probes with variants
were highly imbalanced and ~70% were associated with high B expression. Of 408 cis
eQTL genes represented by probes with variants, 193 could be compared with results
from ASE analysis, and 149 genes showed the same direction of expression bias as ASE.
A total of 1,215 genes were associated with cis eQTLs.
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Cis-modulated genes from ASE and eQTL mapping overlap
We compared results from ASE with those from eQTL mapping. Of the 3,431
genes that were jointly tested, 1,808 (~50%) and 867 (~25%) were identified as cismodulated by ASE and eQTL mapping, respectively. Six hundred and eighty-three genes
were jointly identified as cis-modulated, a significant overlap (hypergeometric p < 10-73),
and ~90% had the same effect polarity. One thousand one hundred and twenty-five and
184 cis-modulated genes were exclusively identified by ASE and eQTL mapping
respectively. In other words, roughly 80% of cis eQTLs also have ASE differences and
~40% of ASE differences are associated with cis eQTLs. To investigate discrepancies,
we compared LOD scores of jointly identified cis-modulated genes with those only
identified by eQTL mapping. The joint set exhibit significantly higher LOD scores (p <
10-5) (Figure 3-4). We further compared the RNA-seq read depth (expression) of these
two groups and the joint set has significantly higher expression (three-fold difference, p =
.03, Figure 3-5). This suggests that the ASE analysis lacks adequate read depth
(statistical power) to detect allelic differences corresponding to cis eQTLs with
comparatively low LOD scores. We performed an empirical power analysis (Figure 3-6)
to illustrate dependency of ASE analysis on read-depth to detect allelic differences of
different magnitudes. As expected, strong differences can be reliably detected with a
relatively small number of reads and vice-versa. The joint set also has higher allelic
expression differences compared to 1,125 genes identified only by ASE (p < 10-30)
(Figure 3-7 :HXVHGDVWULQJHQW/2'WKUHVKROGWRGHILQHcis eQTLs and this will
reduce the number of cis eQTLs corresponding to genes with low ASE. We therefore
performed single marker analysis at less stringent FDR < 0.1 (Methods) to identify cismodulated genes and compared them with the ASE gene set. The number of jointly
identified genes increased from 683 H47/PDSSLQJ/2' WR VLQJOHPDUNHU
analysis, FDR < 0.1), and those exclusively identified by ASE were reduced from 1,125
to 774. Thus a large fraction of disjoint between ASE and eQTL results are explained by
the different statistical criteria and thresholds we used to define both ASE genes and cis
eQTLs.

Genetic variants affecting transcript abundance and protein abundance show poor
overlap
We performed linkage based protein QTL (pQTL) mapping on liver proteomics
data generated from a set of 38 BXD strains [219]. One hundred and seventy-two
autosomal proteins involved in metabolism were quantified using a targeted mass
spectrometry method. Only 7% (n = 12) are associated with cis pQTLs, including
ABCB8, ACADS, ACOX1, ATP5O, BCKDHB, CAR3, DHTKD1, GCLM, MRI1, NNT,
PM20D1, and TYMP (Figure 3-8, where a cis pQTL must have a LOD > 2 located
within ±5 Mb of the parent gene). Not surprisingly, all of the cis pQTLs are also
associated with significant ASE differences with matched polarity. Similarly, 8 of these
cis pQTLs are linked to cis eQTLs with high LOD scores and with matched polarity.
However, 39 genes with significant ASE and 18 genes with significant cis eQTL are not
associated with cis pQTLs. For example, Ddah1 has significant ASE
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Figure 3-4.

Comparison of LOD scores

Notes. Comparison of LOD scores from jointly identified cis-modulated genes (ASE and
eQTL mapping, left boxplot) with those only identified using eQTL mapping (right
boxplot). The Y-axis represents LOD scores. Outliers are not shown.
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Figure 3-5.

Comparison of RNA-seq read depth (log10)

Note. Comparison of RNA-seq read depth (log10) from jointly identified cis-modulated
genes (ASE and eQTL mapping) with those only identified using eQTL.
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Figure 3-6. Empirical determination of read depth required to detect allelic
differences of a given size
Notes: Each circle represents a SNP. The X-axis represents the measured fold-difference
and the Y-axis represents RNA-seq read depth (log10) for a given SNP. SNPs exhibiting
$6(DWDQ)'5WKUHVKROGRIKDYHEHHQSORWWHGDVFLUFOHV5HGFLUFOHVUHSUHVHQW
613VZLWK$6(DWDQ)'5WKUHVKROGRI0.01. The red and blue circles, combined,
UHSUHVHQW613VZLWK$6(DWDQ)'5WKUHVKROGRI6LPLODUO\UHGEOXHDQG\HOORZ
FLUFOHVFRPELQHGUHSUHVHQW613VZLWK$6(DWDQ)'5WKUHVKROGRI
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Figure 3-7.

Comparison of absolute allelic differences

Notes. Comparison of absolute allelic differences from jointly identified cis-modulated
genes (ASE and eQTL mapping, left boxplot) with those only identified using ASE (right
boxplot). Outliers are not shown.
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Figure 3-8.

Comparison of cis-acting variation at transcript versus protein levels

Notes. The X-axis and Y-axis represent LOD scores for genes and cognate proteins
measured at their closest markers (cis LOD). A LOD of 2 (dashed line) roughly
corresponds to a nominal p < 0.01.
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(3±4 fold difference) and a strong cis eQTL (chr3:145 Mb, LOD ~ 14.5) favoring the B
allele. However, the protein difference across BXDs does not map to the location of gene
and protein difference between B and D alleles has a one-tailed p of 0.2²a reasonably
strong negative result. This case is doubly interesting because variation in DDAH1
protein maps as a trans pQTL (Chr7: 27.85 Mb, LOD ~ 2.5).

Majority of aberrant alleles do not affect expression severely
Nonsense mediated decay (NMD) is a molecular surveillance mechanism that
selectively degrades aberrant transcripts produced as a result of nonsense or splice-site
variants [234-236]. NMD of aberrant transcripts should result in extreme allelic ratios
(close to zero or one). However, over two-thirds of nonsense variants (transcripts) in
human cell lines escape NMD through unknown mechanisms [237]. We measured allelic
ratios for 12 nonsense variants (transcripts) and remarkably only two²Gbp11 (0.05, high
D) and Mug2 (0.90, high B)²had extreme ratios across multiple SNPs. Interestingly, half
of the stop codon losses identified in the B allele only add one to two amino acids to the
variant proteins, including VMN2R79 (+1 amino acid), ADAM3 (+1), SPNS3 (+2),
ZCCHC9 (+2), DLGAP5 (+2), and HOGA1 (+1). None of these transcripts have extreme
allelic ratios. We found that a third of murine genes have one or more in-frame stop
codons in close vicinity (<30 nucleotides) to the original stop codon. Tandem stop
codons are also known to be conserved in yeast [238], and may provide a safeguard
against stop codon losses. We also evaluated 36 splice-site variants and only five of these
transcripts, including Cyp2c39 (0.02), Arhgef10 (0.03), Pik3c2g (0.05), Lox14 (~0.9), and
Rpsa (0.99) had extreme ratios.
In conclusion a majority (> 85%) of presumed aberrant transcripts including
nonsense and splice-site variants escape NMD. We speculate that the use of alternative
stop codons or splice sites in the immediate vicinity of the primary mutation apparently
prevents aberrant transcript production.

Mechanistic insights into the basis of allele-specific expression²quantitative and
qualitative differences
Cis-acting variants affect expression in three major ways: (1) by modulating
transcription rates and stability (mRNA abundance), (2) by modulating transcript
processing (splicing and polyadenylation), and (3) by altering mRNA transport and
storage [239]. Allelic ratios of SNPs that represent different regions of a transcript can be
collectively analyzed and compared to provide mechanistic understanding of these
alternative mechanisms. Multiple SNPs that have the same polarity and roughly the same
magnitude of effect suggest variants in enhancers or transcription-factor binding sites that
control transcript levels globally. For example, Gclm, a gene involved in the metabolism
of dietary lipid [240], that also has a strong cis pQTL (LOD ~5) in liver with high
expression of the B allele. All five SNPs have ASE with the same polarity. Another
example is Nnt, a gene linked to insulin hypersecretion in the D parent [241], has a strong
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cis pQTL (LOD ~8) in liver with high expression of the D allele. All eight SNPs exhibit
significant ASE and with the same polarity (Figure 3-9a).
Neighboring SNPs located within 5¶RU¶875VWKDWKDYHRSSRVLWHSRODULW\
suggest allele-specific differential usage of alternate transcriptional initiation or
polyadenylation sites. One example is Txndc9, a gene linked with colorectal cancer in
humans [242]. This gene has multiple transcripts with alternative polyadenylation sites as
demonstrated by multiple mRNAs in RefSeq and Ensembl gene models. Two SNPs
located in exons 1 and 3 have significantly ASE with high B expression whereas eight
613VORFDWHGLQWKHH[WHQGHG¶875 Figure 3-9b) have high D expression suggesting
allele-VSHFLILFGLIIHUHQFHVLQ¶875SURFHVVLQJ$VLPLODUSDWWHUQLVREVHUYHGLQDUUD\
data: probe sets in coding exons have high B expression wKHUHDVWKRVHLQWKH¶875
have high D H[SUHVVLRQ7KHORQJHU¶875RIWKHD allele harbors putative binding sites
(PhastCons > 0.5 and mirSVR score < -0.3 [243]) for multiple miRNAs, including miR539, miR-96, miR-129-5p, that may explain overall low expression of the D transcript.
Another example is Slc38a3, a glutamine transporter involved in ammonigenesis
[244,245]. GenBank and Ensembl gene models demonstrate multiple transcripts that use
DOWHUQDWLYHWUDQVFULSWLRQDOLQLWLDWLRQVLWHV)RXU613VLQH[RQVDQGD613LQ¶875KDYH
high D H[SUHVVLRQ+RZHYHU613VLQWKH¶875KDYHYDULDEOH$6( Figure 3-9c). Two
SNPs (rs30029220 and rs29646102 H[FOXVLYHWRWKHORQJHU¶875KDYHKLJKD
expression whereas a SNP (rs3672647 LQWKHVKRUWHU¶875KDVKLJKB expression
suggesting that the D DOOHOHIDYRUVXVDJHRIWUDQVFULSWZLWKWKHORQJHU¶875
Finally, SNPs with opposite ASE polarity in different coding exons are probably
caused by alternative exon usage or alternative splicing. For example, carbonic anhydrase
3 (Car3), a gene linked to adipogenesis [246], has a strong cis pQTL (LOD ~5) with high
expression of the D allele. Five SNPs located exclusively in a long isoform show
significant ASE with high D H[SUHVVLRQRQH613LQWKHH[RQDQGIRXU613VLQWKH¶
UTR (Figure 3-9d). In contrast, 5 SNPs located exclusively in the short isoform have
high B expression.

DISCUSSION
Allele-specific expression differences are a major driver of phenotypic differences
and variation in disease risk. We exploited RNA-seq and eQTL data sets to quantify the
extent and intensity of cis-acting variation in expression in liver. After correcting for
alignment bias, we achieved the expected symmetrical distribution of allelic differences.
Well separated SNPs within single exons are highly concordant both in strength and
polarity of effects.
Having dealt with these technical challenges, we were able to identify statistically
significant ASE differences with minimum fold difference of 1.25x for nearly half of all
assayed transcripts. This latter finding strongly supports recent work by Crowley and
colleagues [204] demonstrating pervasive and high levels of ASE in brain and other
tissues. In each F1 strain contrast, they detected significant ASE in 50% or more of all
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Figure 3-9. Schematic examples of genes potentially associated with different
categories of cis-regulatory mechanisms
Notes. The Y-axis shows the allelic ratios of SNPs located within the gene. An allelic
ratio greater than 0.5 (dashed line) represents high expression of the B allele. Examples of
allele-specific regulation of (a) overall gene expression, (b) ¶875SURFHVVLQJ(c) ¶
UTR processing, and (d) isoform usage.
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tested genes/transcripts at an FDR of 0.05. In total, 90% of testable genes exhibited ASE
effects in at least one pair of strains. Lagarrigue and colleagues [214] detected somewhat
less pervasive ASE effects (~20%) in liver of C57BL/6JxDBA/2J F1 animals, but this is
most certainly a matter of lower RNA-seq read depth (statistical power), and a higher
fold difference (1.5X) criterion they used to identify ASE. Of 2,256 genes, they only
observed 383 genes with significant ASE. We are now able to address three questions
posed in the introduction.

Highly conserved genes have low levels of ASE
Do differences in the magnitude of ASE represent differences in complexity of
expression control or in evolutionary history? To answer these questions we compared a
group of genes with very low and very high ASE. We found no differences in the density
of cis-regulatory elements, but genes with low ASE do appear to be under more intense
purifying selection. Fifty percent of the non-ASE set are house-keeping genes [230] and
are likely to evolve comparatively slowly [247,248]. In contrast, genes with high ASE are
likely to have higher functional redundancy as estimated indirectly by numbers of
paralogs, and they are also enriched in tissue-specific functions. In our study of liver they
are involved in the metabolism of lipids, fatty acids, and xenobiotics. We speculate that
high gene sets with higher ASE may function in tissue-specific pathways that tend to
retain both higher numbers of paralogs and be under less evolutionary constraint. The
comparatively high range of variation in expression of these genes may be crucial to
conferring greater physiological tolerance to noise and environmental challenges. ASE
may also be one of the genetic mechanisms that underlie the canalization of phenotypes
[249,250]

Poor overlap between variants affecting transcript and protein abundance
Transcript abundance has been shown to correlate only modestly with protein
abundance. [219,251-254]. As expected, there is considerable disparity in allelic variation
detected at mRNA and protein levels. A few of the cis eQTLs with very high LOD scores
 EXWHVVHQWLDlly no cis pQTLs (LOD score < 1) are Ddah1, Gadd45gip1 and
Aldh4a1. Fu and colleagues suggested an increased buffering at the level of proteins and
metabolites, such that only a few genetic variants modulate major phenotypic variation
and majority of them remain silent [255]. Factors that are known to contribute towards
the disparity between mRNA and protein levels include post-transcriptional and posttranslational modifications [254], differences in half-lives [256], variability in mRNA
expression level due to changes in cell-cycle [257].

Comparison between ASE and eQTL mapping results
We found significant overlap in cis-modulated genes identified by ASE and eQTL
analysis, despite substantial differences between methods and assays. Eighty percent of
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cis eQTL genes are also detected by ASE, and ~90% of them have the same polarity. The
set of 683 genes identified by both methods have significantly higher LOD scores than
the set of 184 genes identified only by eQTL mapping. In our work, when ASE methods
fail to detect known eQTLs, this is almost certainly due to inadequate read depth
(statistical power). High sampling error in RNA-seq data will affect power of ASE
analysis especially for genes with low expression [82,258]. As shown above, high read
depth is required to detect small allelic difference. A small fraction of presumed cis
eQTLs can be local trans eQTL effects of neighboring genes.
The jointly identified set of ~650 genes has greater allelic differences than the set
of 1,125 genes identified only by ASE. A large fraction of subtle allelic differences
identified only by ASE may have been confounded by noise or epistatic trans-acting
effects in the eQTL analysis. The small sample size of the BXD cohort used for the eQTL
mapping may not have adequate statistical power to map weak cis eQTLs, especially in
the presence of epistatic trans eQTLs. Additionally, the LOD threshold of greater than 3
used to define cis eQTLs may be too stringent in this particular context.
To the best of our knowledge, Babak and colleagues [259] were the first to
compare F1-derived ASE results with eQTL results from F2 intercrosses for adipose and
islets samples. They found an 80% overlap between genes exhibiting ASE and genes with
cis eQTLs. Lagarrigue and colleagues [214] found a 60% overlap between the methods.
Hasin-Brumshtein and colleagues [260] performed a similar comparison in adipose tissue
and reported relatively poor overlap (~20%), but as noted above, differences with our
more concordant results are most likely cumulative result of differences in criteria and
ratios of statistical power of ASE analysis using F1 hybrids and cis eQTLs analysis using
large intercrosses.
As highlighted in the introduction, it is now clear that most common variation in
phenotype and disease risk are linked to variants that modulate patterns of gene
expression. ASE is a sensitive and a cost-effective method to detect cis-acting differences
in expression. Environmental and trans-acting factors are fully controlled in isogenic F1
individuals, and ASE analysis only requires a small F1 sample size. In this respect it has a
clear advantage over eQTL analysis of segregating populations. However, many classical
laboratory strains have been derived from ancestral stock with limited haplotype
diversity. As a result, a large fraction of an F1 genome will be identical by descent (IBD)
and genes in these regions cannot be interrogated using ASE.
Linkage-based eQTL analysis adds two important dimensions to an ASE study.
First, it makes it possible to assign causality to specific variants using high-resolution
mapping populations [88,89]. Second, eQTL analysis makes it possible to study the
downstream effects of differential expression. These downstream effects are detected as
trans eQTLs of other mRNAs or proteins.
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ASE varies between different environments and genetic backgrounds
Estimates of ASE and cis eQTL will vary as a function of genetic background
[204], tissue [172], environment [219], and sex [261]. For example, cis eQTLs effects can
be strongly dependent on diet. The cis eQTL associated with Ndusf2 increases from LOD
score of 2 in a mouse cohort on a normal chow diet to a LOD score of 6 in a cohort on a
high fat diet [219]. For these reasons, one should not expect estimates of ASE in liver of
one population or treatment to generalize. Nevertheless, many of the large ASE effects
caused by strong cis-acting variants will often be well conserved across environments,
cell types, and genetic backgrounds. For example, ASE effects due to copy number
variants [199]UHWURWUDQVSRVRQVGLVUXSWLQJ¶875V[88], and nonsense mutations [262]
will often produce strong and consistent ASE effects across many tissues and treatments.
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CHAPTER 4. SYSTEMATIC PHENOME-WIDE ASSOCIATION USING BXD
RECOMBINANT INBRED STRAINS OF MICE TO TEST GENE FUNCTION
AND DISEASE RISK

SYNOPSIS
Phenome-wide association is a novel reverse genetic strategy to analyze genometo-phenome relations in human clinical cohorts. Here we test this approach using a large
murine population segregating for ~5.5 million sequence variants, and we compare our
results to those extracted from a matched analysis of gene variants in a large human
cohort. For the mouse cohort, we amassed a deep and broad open-access phenome
consisting of 4,230 metabolic, physiological, pharmacological, and behavioral traits, and
more than 80 independent eQTL transcriptome, proteome, metagenome, and metabolome
datasets²by far the largest coherent phenome for any experimental cohort
(www.genenetwork.org). We tested downstream effects of subsets of variants and
discovered several novel associations, including a missense mutation in fumarate
hydratase that controls variation in the mitochondrial unfolded protein response in both
mouse and C. elegans, and missense mutations in Col6a5 that underlies variation in bone
mineral density in both mouse and human. Unlike genome-wide association, negative
results in a deep phenome scan can be informative. Downstream effects of allelic variants
with presumed deleterious effects on protein structure or mRNA and protein levels are
often small or undetectable.

INTRODUCTION
Identifying sequence variants that control sets of linked phenotypes is
fundamental to understanding the molecular basis of both Mendelian and complex traits
[172,263-265]. A variety of reverse genetic approaches to induce loss- and gain-offunction have been used to causally tie DNA variants to discrete phenotypes [266].
However, reverse genetics presents two challenges. The first is evaluating a potentially
broad spectrum of phenotypes, biomarkers, and endophenotypes that are downstream of
sequence variants at different stages of development and under different conditions. The
second is evaluating the impact of these variants across different genetic backgrounds
that influence trait penetrance. Phenome-wide association studies (PheWAS) have been
developed recently to address both challenges [59,267]. In order to establish the first
murine resource for phenome-wide association we have used a large cohort of strains²
the BXD family²that we generated by crossing two fully inbred strains²C57BL/6J and
DBA/2J. We have discovered novel genetic associations and have translated them to a
clinical cohort through human PheWAS using electronic health record (EHR) data. The
use of systematic phenome scanning provides an exemplar of an effective paradigm for
genome-to-phenome mapping and the analysis of pleiotropic genetic effects.
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MATERIALS AND METHODS

C. elegans experiments
C. elegans were cultured at 20°C on nematode growth media agar plates seeded
with bacteria. Strains were provided by the Caenorhabditis Genetics Center (University
of Minnesota). The strains used were SJ4100 (zcIs13[hsp-6::GFP]), SJ4005 (zcIs4[hsp4::GFP] and dvIs70 [hsp-16.2p::GFP + rol-6(su1006)]. RNAi constructs were isolated
from the RNAi feeding library (GeneService) and experiments were carried out using
standard feeding methods. The identity of each RNAi clone was verified by sequencing.
RNAi treatment was started from embryonic stage. GFP was monitored in day 1 adults.
Worms were immobilized with 6 mM solution of tetramisole hydrochloride (Sigma) in
M9 and imaged using Nikon DS-L2 fluorescent microscope.

Organization and categorization of mouse phenome
The BXD Phenotype database has been amassed by literature review, direct data
entry by our team, and by collaboration with many investigators. Data are reviewed prior
to entry in GeneNetwork by the senior author. Phenotypes are currently split into fifteen
broad phenotypic categories (www.GeneNetwork.org). Phenome curation and description
was initiated by RWW and Dr. Elissa Chesler in 2002 by literature review and data
extraction. The early work is described briefly in Chesler and colleagues [268,269]. We
have used a controlled vocabulary and set of rules described here
(http://www.genenetwork.org/faq.html#Q-22 'HVFULSWLRQVLQFOXGHD³SUHIL[´RIPDMRU
ELRORJLFDODQGGRPDLQFDWHJRULHVVXFKDV³FHQWUDOQHUYRXVV\VWHP´³FDQFHUELRORJ\´
³LPPXQHV\VWHP´7KHVHGRPDLQVKDYHEHHQXVHGWRGHILQHPDMRUFDWHJRULHVXVHGLQ
figures and graphs.

PheWAS analysis in mice
PheWAS were performed for a total of ~11,000 variants, including 10,895
missense, 61 nonsense, 196 splice site, 99 frame shift mutations, and 215 CNVs The
closest marker for each variant from a set of 3,804 genetic markers²each representing a
unique haplotype block²was used to represent that variant in the PheWAS. A total of 84
expression datasets were used for calculating the number of mRNA assays. Among these,
16 datasets highlighted in grey were further used for molecular phenome scan analysis.
Similarly, we used 4,236 classic phenotypes from GeneNetwork.org
(www.genenetwork.org) to study the association between variants and phenotypes. We
calculated the p value of the Pearson correlation between each marker (variant) and 4,236
phenotypes and ~40,000 transcripts for the expression data. All p values of correlation
were calculated as a two-tailed test, and the q values (false discovery rate; FDR) were
calculated using QVALUE[270]. We used an FDR threshold of 0.01 for associations. The
analyses were performed using in-house Python scripts, and the R statistical package.
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PheWAS analysis using GeneNetwork.org
The PheWAS analysis can be performed in GeneNetwork
(www.GeneNetwork.org) by simply following these three steps. We use an example of a
missense variant (Chr2: 25,398,350) in Entpd2: Step 1: Find a marker closest to the high
impact sequence variant of interest identified by our deep resequencing of the DBA/2J
genome. We can search for the closest marker located on Chromosome 2 at 25.39 Mb by
VHDUFKLQJWKH%;'*HQRW\SHGDWDVHWXVLQJDVWULQJVXFKDV³3RVLWLRQ &KU ´
where 25 and 26 are the proximal and distal search regions on Chr 2 measured in
megabases. This will return a list of markers²mainly SNPs and microsatellites²close to
the high impact sequence variants in Entpd2. From the list of markers, we selected
rs8250941, located within ~100 Kb of the high impact sequence variants. Step 2:
Compute correlations between this marker and all ~4000 BXD phenotypes. In the case of
rs8250941, GeneNetwork traits 10015 and 10014 are highly correlated with this marker
and have ±logP association scores larger than 10. Traits that have peak association scores
(LRS or LOD) that are very close to the location of sequence variants are candidate traits.
Step 3: Compute correlations between the marker and all or a subset of relevant
transcriptome or proteome data sets. This may produce large output tables with as many
as 20,000 endophenotypes. However, these can be sorted easily by the position of the
peak association score (click on column that is labeled Max LRS Location). When
correctly sorted, this table will highlight those candidate mRNAs that presumably map to
sequence variants at the Entpd2 locus.

PheWAS in humans
PheWAS for human data was performed using 29,722 individuals with Illumina
HumanExome array data identified as European ancestry in the EHR and by using
Structure[271]. To define diseases, we mapped International Classifications of Diseases,
9th edition, (ICD9) codes from the EMR into 1,645 possible PheWAS phenotypes using
methods described previously[267]. PheWAS phenotypes aggregate like ICD9 codes
together (e.g., type 2 diabetes codes as a specific phenotype), are hierarchical (e.g.,
³LQIODPPDWRU\ERZHOGLVHDVH´LVDSDUHQWRI³&URKQ¶VGLVHDVH´DQG³8OFHUDWLYHFROLWLV´ 
and include logic to select controls for each case definition. We considered only
phenotypes with at least 20 individuals for analysis, and required each case to have at
least 2 ICD9 codes for a PheWAS phenotype to be considered a case (those with only 1
code are neither a case nor a control). Each SNP-phenotype association test was run with
PLINK[272] using logistic regression adjusted for age, sex, and the first three principal
components as calculated by EIGENSTRAT using ancestry informative markers.
Analysis was performed assuming an additive genetic model. These data were aggregated
and analyzed using Perl scripts and the R statistical package. A total of 1501 phenotypes
were considered, for a per-SNP Bonferroni correction of 0.05/1501=3.3x10-5.
We then performed PheWAS for missense SNPs for each of the target genes from
the mouse PheWAS that had minor allele frequencies >1% and passed quality control
filters of SNP call rate >95% and sample call rate >99% in unrelated samples. SNPs were
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found for ENPTD2 (rs34618694), COL6A5 (rs1353613, rs79867908, rs12488457,
rs113396273, rs35886424, rs1453241, rs1497312, rs11917356, rs76864445,
rs16827497, rs16827168, rs819085, rs9883988, rs61744488), AHR (rs2066853), ALAD
(rs1800435), and HDH3 (rs1043836). No SNPs were available for FH1.

RESULTS

Phenomes
Phenome data were generated using a large cohort of recombinant inbred
strains²the BXD family²that was generated by crossing two fully inbred parents²
C57BL/6J and DBA/2J. Members of the BXD family collectively segregate for all
sequence variants that distinguish the two parents²and in this cross these are by
definition common variants. There are also interesting rare but still undefined alleles
unique to each family member. The level of both genetic and phenotypic variation
between parents and among the strains is high (Figure 4-1a). This BXD phenome
includes ~4,500 quantitative metabolic, physiological, pharmacological, toxicological,
morphometric, and behavioral phenotypes (Figure 4-1b). These traits are almost all
quantitative (unlike electronic health care datasets) and have been systematically grouped
into 15 major phenotype categories (www.GeneNetwork.org). We have also generated
and assembled a large molecular phenome that includes expression phenotypes from ~90
large open access expression quantitative trait locus QTL (eQTL) studies generated over
the past decade (www.GeneNetwork.org). On average 1.5 × 106 mRNA, 1.7 × 104
proteomic, and 6.8× 103 metabolomic assays are available per strain (Figure 4-1b). Most
phenotypes vary markedly across strains within the family. For example, effect of highfat and low-fat diets on adult body weight varies substantially across genotypes (Figure
4-1c). Similarly mRNA and protein expression of, for example, Bckdhb and many other
mRNA, proteins, and metabolites vary greatly (Figure 4-1d) [219]. The online
availability of well-organized classic and molecular traits from the BXD family (see
www.genenetwork.org) provides the foundation for multiscalar phenome scans of any
putatively functional sequence variant.
The human phenome used in this study is a large electronic health record (EHR)linked cohort, BioVU. BioVU currently contains >190,000 DNA samples linked to deidentified medical records to provide a large, clinically-relevant human resource to study
genotype-phenotype associations; 29,722 of these individuals have extant exome variant
data, which was used for matched mouse-to-human PheWAS in this study. Informed
consent was obtained from all human participants.

Phenome-wide association analysis in mouse
The functionally important variants (i.e. nonsense, missense, splice site,
frameshift, and CNVs) were selected for subsequent Phenome-wide association study
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Figure 4-1.

Overview of phenome data for the BXD cohort

Notes. (a) Five pairs of isogenic BXD cohort strains²BXD43 to BXD102. There are
now approximately 100 readily available BXD strains and another 50 that are almost
fully inbred. Almost all current phenome data is restricted to the parents, F1 hybrids, and
BXD1 through BXD102. (b) Phenome data categorized by type, including classic
phenotypes (top), metabolic and proteomic trait data (middle), and independent mRNA
expression assays (bottom, n = 86 unique eQTL data sets). (c) Body weight data for BXD
strains on high fat (gray) and low fat (black) diets. (d) Expression of Bckdhb mRNA and
its protein in six tissues for the five BXD strains.
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(PheWAS) analysis (Figure 4-2). We used 3,805 genotypes that represent distinct
haplotype blocks in the BXD family to perform PheWAS against 4,230 classic traits as
well as 602,746 endophenotypic traits from 16 distinct tissues. This analysis yielded ~14
million genotype-to-phenome correlations and ~2.0 billion genotype-to-endophenotype
correlations. A total of 95 genotypes are significantly associated with 321 phenotypes,
corresponding to 108 phenotypic groups, at a stringent q value threshold of <.01
(Supplementary Table 4-1). In addition, we performed differential expression analyses
between the C57BL/6J and DBA/2J strains for each association by using transcripts from
16 tissues and proteins from hippocampus.
We interrogated the associations for 11,466 functionally important variants,
including 10,895 missense, 61 nonsense, 196 splice site, and 99 frame shift mutations,
and 215 CNVs, by mapping these variants to the nearest genotype markers within ±1 Mb.
We found 650 functionally important variants associated with 97 classic phenotypes,
including 634 missense variants associated with 62 phenotypes.

Examples of variant-phenome association
Among 321 classic phenotypic associations meeting a stringent q value threshold
of < 0.01 (Supplementary Table 4-1), a few variants, such as those in Gpnmb, Comt and
Ahr, have been associated previously with disease[88,146,273] using traditional forward
genetics approaches, but the vast majority of variants have not been previously linked to
any phenotype. Here, we provided four PheWAS examples, including three missense
variants (Fh1, Col6a5, Entpd2), a nonsense variant (Ahr), and a CNV (a region covering
both Alad and Hdh3).
The first example is a missense variant (A296T) in the fumarate hydratase
mitochondrial enzyme located on chromosome 1 at 175.60 Mb (Fh1; Figure 4-3a). Fh1
catalyzes the hydration of fumarate to malate in the tricarboxylic acid (TCA) cycle and
has been linked to renal cell cancer[274]. The missense variant in the lyase 1 domain is
associated with a ~1.4-fold effect on expression of Fh1 across many tissues, including
midbrain, hypothalamus, striatum, and spleen (Figure 4-3b). This variant is strongly
associated with Fh1 mRNA expression, as well as the expression of other mitochondrial
genes, including Mrpl50, Sirt3 and Dlst (Figure 4-3c). Expression PheWAS shows that
the Fh1 locus modulates mRNA expression levels of 113 mitochondrial proteins, in
addition to 8 genes linked to renal necrosis, and 7 genes involved in mTOR signaling,
consistent with the known role of FH1 in renal cancer. Interestingly, four mitochondrial
genes, Hspd1, Hspa9, ClpX, and Lonp1 that all encode components of the mitochondrial
unfolded protein response (UPRmt )[87]²a still poorly characterized mitochondrial stress
response pathway in mammals²show strong association with Fh1 (Figure 4-3d). There
is furthermore a significant correlation between Fh1 transcript levels and principal
component scores of a group of UPRmt genes in mouse (Figure 4-3e). In contrast, no
genes involved in the cytoplasmic heat shock response (HSR) or the ER unfolded protein
response (UPRer) are associated with Fh1, indicating a selective association between Fh1
and UPRmt in mammals (Figure 4-3d). To validate this association, we examined the
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Figure 4-2.

Experimental PheWAS analysis using the BXD cohort

Notes. The list of strong sequence and structural variants were selected for phenome
scanning. The Pearson product-moment correlation was used to calculate the association
between variants and classic and molecular phenotypes from 16 tissues. FDRs were
calculated based on p values using QValue method. We used a q threshold of < 0.01.
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Figure 4-3.

Association analysis for a missense variant in Fh1

Notes. (a) Structure of the Fh1 gene showing lysate 1 and fumarase c domains, the latter
of which contains a missense mutation. (b) Combined eQTL mapping of Fh1 mRNA
across 15 tissues. The eigenvalues associated with the first principal component map to
Fh1 with a likelihood ratio statistic (LRS) of >20. The solid red line represents genomewide significance. The yellow triangle indicates the genomic position of Fh1. Three
peaks associated more specifically with single tissue types are labeled. (c) Manhattan plot
of a expression phenome scan of molecular traits linked to the Fh1 locus in midbrain. In
addition to Fh1 transcript, mRNAs for three mitochondrial-related genes (Mrpl50, Sirt3,
and Dlst) are significantly associated with rs4136041. The y-axis shows the ±log10 q
values of association, and the x-axis shows positions of 55,681 probe sets from Agilent
SurePrint array. (d) QTL heat map of mRNAs involved in the unfolded protein response.
The x-axis lists mouse chromosome numbers, compressed for illustrative purposes. Each
horizontal line represents the QTL map for a single transcript in midbrain. Transcripts are
grouped into three major categories²genes involved in the canonical UPRmt, and those
encoding chaperones and heat shock proteins (HSP) and those involved in unfolded
protein responses in the endoplasmic reticulum (UPRer). The subset of UPRmt genes at
the top are strongly modulated by the Fh1 locus on Chr 1 (the intense colors to the upper
left). In contrast, none of the UPRer subsets are modulated by Fh1. (e) Principal
component analysis (PCA) plot for six UPRmt transcripts (left panel). The first two
components explain ~67% of the variance in Fh1 expression in hypothalamus. There is
significant correlation between UPRmt expression and Fh1 (p = 5 × 10-8) (right panel).
(f) Validation that fumarase hydratase selectively controls the UPRmt in C. elegans. The
left-most pair of images demonstrates effects of the fum-1 RNAi knockdown on hsp6::gfp signal²a marker of UPRmt induction. Top images are GFP fluorescence; bottom
panels are matched differential interference contrast (DIC) image with GFP. The middle
and right panels demonstrate that the fum-1 knockdown does not induce either the UPRer
(hsp-4::gfp), or the cytoplasmic heat shock response (hsp-16.2::gfp). (g) Manhattan plot
of a phenome scan. The phenome has been subdivided into 15 categories based on
biological function or tissue type. The y-axis shows the ±log10 q values of ~4,230
phenotypes, and the x-axis shows the 15 categories.
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phenotypic impact of the highly conserved C. elegans Fh1 ortholog, fum-1 (86%
sequence similarity) on unfolded protein responses. RNAi against fum-1 causes robust
activation of the mitochondrial chaperone hsp-6::gfp reporter, indicative of the activation
of the UPRmt (Figure 4-3f). The response was organelle-specific, and fum-1 RNAi does
not induce either hsp-4::gfp or hsp-16.2::gfp, reporters for related to the UPRer or heat
shock response, respectively (Figure 4-3f). Thus, in the BXD family, a decrease of
fumarate hydratase leads to a specific mitochondrial phenotype, characterized by an
UPRmt.
Fh1 is also associated with two candidate phenotypes: (1) T cell proliferation (GN
ID 10237; q = 2.6x10-5), linked previously to mitochondrial function[275], and (2)
dopamine metabolism after treatment with the mitochondrial toxin 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP, GeneNetwork identifier (GNID) 15151; q =0.005).
Both traits are linked to Fh1 along with the control of mitochondrial components of a
UPRmt pathway (Figure 4-3g). No extant human genotype data are yet available for
FH²the ortholog of Fh1.
The second example consists of a set of tightly linked missense variants in
collagen 6A5 on chromosome 9 at 105.76 Mb (Col6a5, Figure 4-4a). Col6a5 is a
variant-rich gene and contains 21 missense variants, including a radical substitution
(R1778C). Quantitative RT-PCR shows higher expression of the D allele than the B allele
in bone marrow (Figure 4-4b). As expected expression differences are strongly
associated with Col6a5 locus in bone expression PheWAS (q = 3.5x10-4, Figure 4-4c).
Unlike Fh1, the high density of linked variants in Col6a5 means that we cannot resolve
effects of single SNPs, but the scan does define effects of B and D haplotypes for Col6a5
across the phenome. We find that this polymorphic gene is associated with differences in
bone mineral density (BMD; GN ID 16532; q =0.037) (Figure 4-4d) and quantitative
micro-CT analysis confirms a marked difference in cortical BMD at the femoral midshaft
between C57BL/6J (1069.6 ± 51.4 mgHA/cm3) and DBA/2J parents (1170.8 ± 39.8
mgHA/cm3) (Figure 4-4e, Figure 4-4f). In humans, mutations in collagen VI are
associated with a variety of musculoskeletal abnormalities[276]. We performed a
matched PheWAS in human using the BioVU resource and linked rs113396273 in exon 3
of COL6A5 (M56T) with osteopenia and other bone and cartilage disorders (p = 1.4x10-3;
Figure 4-4g). Like rs113396273, the other SNPs tested in COL6A5 demonstrated similar
patterns of associations including respiratory abnormalities and giant cell arteritis.
The third example involves missense variants²R149Q and A297T²in ectonucleoside triphosphate diphosphohydrolase 2 (Entpd2; Figure 4-5a). These variants in
the triphosphatase domain are linked to differences in mRNA (fold-difference = 0.6, p
value <.03) and protein levels (fold-difference = 1.7, p <.01) (Figure 4-5b) and generate
strong cis eQTLs in multiple tissues (e.g., lung, q = 4.9×10-9). A phenome scan highlights
two enzymatic phenotypes: (1) Ca2+- and (2) Mg2+-stimulated ecto-ATPase activity
(GN ID 10014 and 10015; q = 9.97×10-5 and .007) (Figure 4-5c). Both are direct
measures of ATPase activity²prima facie evidence that one or both of these SNPs are
causal. In the BioVU human clinical cohort, rs34618694 in ENTPD2, is associated with
microophthalmia (p = 2.4x10-4) and visual defects (p = 2.2x10-3; Figure 4-5d).
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Figure 4-4.

Association analysis for missense variants in Col6a5

Notes. (a) Twenty missense variants in Col6a5 distributed across 10 von Willebrand
factor A-type (vWFA) domains. (b) Differential mRNA expression of Col6a5 in tibias (n
= 4) measured by rtPCR. The D haplotype (blue, right) has far higher expression than the
B haplotype (green) relative to Gapdh. (c) Phenome scan of Col6a5 (rs13480398) across
mRNA assays for femur. (d) Phenome scan of Col6a5 (rs13480398) across classic
phenotypes. (e) Marked difference in bone density between C57BL/6J and DBA/2J
parents. Femurs from 12-week-old mice were scanned using high-resolution micro-CT
ȝ&76&$1&20HGLFDO%DVVHUVGRUI6ZLW]HUland). More highly mineralized areas
are indicated in red. (f) Difference in material bone density (p = 0.02; two-tailed
6WXGHQW¶VW-test, n = 3). (g) Human phenome scan for association of Col6a5
(rs113396273) across BioVU.
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Figure 4-5.

Association analysis for missense variants in Enptd2

Notes. (a) Structure of the Entpd2 gene showing two missense mutations and GDA/CD39
family domain. (b) Entpd2 expression differs at both the mRNA and protein levels
between C57BL/6J and DBA/2J strains (n = 3 replicates/genotype). (c) Phenome scan of
Entpd2. (d) Human phenome scan of ENTPD2 across thousands of clinical records using
BioVU Denny et al. (2013). The SNP rs34618694 was selected for this scan. Three
clinical traits related to eye diseases are highlighted. The red dotted line is at p < 0.01.
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The fourth example is a high impact nonsense variant²a lost stop codon in the D
allele of Ahr. Ahr is an important transcription factor that modulates P450 gene
expression in response to xenobiotics such as dioxin[277]. Although the effects of this
SNP on protein length are already known[190] (Figure 4-6a), the pleiotropic
consequences of this mutation have not been evaluated. This variant is significantly
associated with mRNA (q = 1.7×10-3; Figure 4-6b) and protein abundance of Ahr in liver
(q = 0.0085; Figure 4-6c). Classic PheWAS linked this variant to the frequency with
which cleft palates is induced by 2,3,7,8-tetrachlorodibenzofuran injection (GN ID
10714; q = 3.2×10-3) (Figure 4-6d). Ahr variants have also been definitively linked to
differences in locomotor activity[262]. Consistent with the results of the BXD PheWAS,
a matched PheWAS in humans using BioVU links rs2066853 in AHR with cleft palate (p
= 0.012; Figure 4-6e).
In the final example, we tested the effect of copy number variants on gene
expression and phenotypes. A CNV region on chromosome 4:62.49-62.52 Mb that spans
both Alad and Hdhd3²is interesting and involves a 4X expansion in strains with the D
haplotype. The 30 kb CNV is otherwise identical by descent (Figure 4-7a). This CNV is
linked with high variation in mRNA expression of Alad and Hdhd3 in multiple brain
regions (Figure 4-7b, Figure 4-7c), lung (q = 2.1×10-7), eye (q = 1.3×10-10), and liver (q
= 9.2×10-4). Quantitative proteomics of hippocampus confirms significant upregulation
(ALAD 2.3-fold, p < 0.01, HDHD3 1.5-fold, p < 0.01). The CNV expansion of Alad and
Hdhd3 is strongly linked to two classic phenotypes: pain response (GN ID 11307; q =
7.8×10-3) and deoxycorticosterone levels in cerebral cortex (GN ID 12568; q = 2.6×10-4)
(Figure 4-7d). A matched phenome scan in human demonstrates that rs1800435 in
ALAD is associated with chronic pain (p = 2.2×10-2) (Figure 4-7e).

Phenotypic resilience
One surprising finding is that a large proportion of genes with variants that we
initially believe would have high phenotypic impact failed to associate with any classic
phenotypes, or even with molecular endophenotypes. Among 41 confirmed nonsense
variants with high predicted impacts, 12 nonsense variants failed to associate with any
endophenotypes (across scans of 16 transcriptome data sets in different tissues) or with
classic phenotypes at q < 0.01. Failure to detect associated phenotypes could be
interpreted as false negative results or inadequate phenome coverage, but we suspected
that most commonly this reflects molecular resilience that buffers the phenotype from
apparently strong homozygous mutations.

DISCUSSION
We have evaluated the phenotypic effects of a spectrum of genetic variants in a
large mouse cohort by phenome-wide association. The variety and depth of phenotype
data that we have assembled over the last decade for the BXD cohort make this the
largest coherent multiscalar data set for any segregating population. Of course, there are
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Figure 4-6.

Association analysis for nonsense variant in Ahr

Notes. (a) Structure of the Ahr gene showing three domains with a nonsense mutation and
five missense mutations. The nonsense mutation (*805R) leads to loss of the stop codon,
and the addition of 43 C-terminal amino acids. Dotted rectangle to the right is the
extended coding region in the D haplotype. (b) Phenome scan of Ahr (rs3711448) across
mRNA assays for liver. (c) Phenome scan of Ahr across classic phenotypes. Both AHR
protein level and cleft palate induced by TCDF injection are strongly linked to Ahr. (d)
Manhattan plot showing the association in human between SNP (rs2066853) in AHR and
classic phenotypes. The cleft palate phenotype is also associate with AHR in human
clinical cohorts.
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Figure 4-7.

Association analysis for CNV covering Alad and Hdhd3

Notes. (a) The CNV region for Alad and Hdhd3 derived using read-depth information
from genome sequencing. Red dots represent at least a two-fold increase in coverage
compared to the reference genome. The x-axis shows the reference genomic position of
the CNV. Two gene models (i.e. Hdhd3 and Alad) are shown in the CNV plot. (b and c)
Rank ordered mean expression levels of Hdhd3 and Alad across 67 BXD strains, their
parental strains, and F1 crosses. Expression values are normalized on a log2 scale (mean
± SE). Strains with D alleles (red) have higher levels of Alad and Hdhd3 compared to B
alleles (green). F1 hybrids (blue) are intermediate. The comparison between B and D
alleles for Alad and Hdhd3 are shown in an inset boxplot. (d) The phenome scan of the
BXD cohort highlights several interesting potential phenotypes including thermal
nociception, brain deoxycorticosterone levels, and antigenic activity in the spleen. Two
triangles represent pigmentation traits that we know they are associated with a variant in
the linkage disequilibrium block. (e) Manhattan plot showing the association in human
between a SNP (rs1800435) in ALAD and classic phenotypes.
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an almost unlimited numbers of ways to extend this BXD phenome²from much more
extensive GXE studies to single cell omics, but at the current size, the phenome is
certainly large enough to explore the utility of PheWAS in an experimental population.
We demonstrate that phenome scans can be effective at linking sequence variants to a
range of phenotypes and can be used to identify novel and unexpected genome-tophenome relations, or to validate hypothesized associations from independent studies.
Coupling mouse and human PheWAS cohorts also shows great promise, and provides an
efficient method to validate and translate key genome-to-phenome relations.
The novel associations demonstrated in this study provide insight into the genetic
basis of complex traits and variation in disease susceptibility. The missense variant in
Fh1 is a case in point. A variant in Fh1 is linked to the UPRmt, a protective stress
pathway specific to mitochondria, and we confirmed that downregulation of fum-1, the C.
elegans homolog of Fh1, activates the UPRmt. Various disturbances have been shown to
induce the UPRmt, including treatment with paraquat, a pesticide that strongly induces
reactive oxygen species[278], activation of mitochondrial biogenesis[87], overexpression
of aggregation-prone mitochondrial proteins[279], and interference with electron
transport chain protein expression and assembly[87,280]. Here, we show that a purely
metabolic perturbation, such as induced by loss of function of the TCA cycle component,
fumarate hydratase, can activate the UPRmt. While we have detected a single missense
variant in Fh1, the molecular cascade that links Fh1 to other tricarboxylic acid cycle
(TCA cycle) genes (e.g. Dlst, Sdha, Sdhb) and a UPRmt proteostasis regulatory loop
requires additional analysis.

Advantages and disadvantages of PheWAS
Recent work has demonstrated that phenome scans are a powerful way to link
from sequence variants to sets of phenotypes in clinical cohorts [59,267]. Here we have
extended this approach to a murine cohort for which we have been generating cellular
and molecular traits from many tissue and cell types and for which we can generate data
on gene-by-environment interactions [75,86,219]. Despite strong functional effects of
variants in humans, the minor allele frequencies are often too low to attain sufficient
sample size. Murine populations such as the BXDs, the Collaborative Cross, and
heterogeneous stock typically have linkage disequilibrium that is at least an order of
magnitude larger than in humans. Consequently, the assignment of specific causality may
be erroneous. For example, in the BXD family about 20,000 protein coding genes and
12,000 coding variants are distributed across ~4,000 haplotype blocks. Increasing the size
and genetic diversity of a reference population and the number of recombination events
can improve genetic resolution, but a more effective and meaningful solution,
exemplified in this study, is to exploit other mouse cohorts and human cohorts for
validation and cross-species translation. For example, by having multiple phenomes for a
single species, along with matched databases of segregating sequence variants, it would
become practical to rapidly test the replicability of genome-phenome relations. It may
soon be practical to compare the BXD phenome with that of the Collaborative Cross and
other large families of RI strains. Any cohort will only segregate for a subset of possible
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sequence variants, and variants will often not be shared across populations or species. For
this reason, conservation of gene function will be a more useful currency of exchange
[281,282].
While PheWAS has great potential, this approach faces several hurdles to more
widespread application. The first is simply the technical and logistical challenge of
generating a phenome. Intense collaborative efforts are a sine qua non even for the most
tractable model organisms such as Drosophila [283]. The second is yet another example
of the multiple testing problem: what is the appropriate correction given the size of the
phenome and its structure? We have computed FDR q values at a conservative threshold
and have aligned our results, when possible, with the BioVU clinical cohort. However, in
both species, the selection of appropriate q values will depend on the purpose of studies
and the relative costs of Type 1 and Type 2 errors. Effective solutions may require
adjusting thresholds based on the scope and intent of studies, as well as prior information
about gene-to-phenotype relations. Alignment of phenotype associations across both
humans and mice, however, adds validity to both. Very large, densely genotyped or
sequenced populations will be needed to more deeply interrogate the human phenome.
The third problem is linkage disequilibrium. The intervals in which sequence variants are
located is a critical factor in mapping its phenotype spectrum. Pleiotropy will be inflated
as a function of gene density, SNP density, and haplotype block structure. Deconvolving
contributions of linked polymorphisms will, in most cases, still require independent
experimental validation and, when possible, PheWAS of human cohorts.

Phenome resilience
We searched for molecular or functional consequences of ~12,000 coding variants
segregating in the BXD family, and we were surprised that only a small fraction had
strong effects on mRNA and protein expression, let alone on classic phenotypes. Initially,
this observation was surprising to us. A first factor contributing to phenotypic resilience
comes from the depth of the phenome ± in fact some phenotypic differences will only be
observed under certain environmental conditions. For example, functional effects of the
well-known mutation in the Nnt gene will be much more pronounced under metabolic
stress [219]. Phenotypic resilience can also be caused by the presence of in frame stop
codons or splice acceptor or donor sites in the vicinity of the original disrupted site,
which may generate almost normal and non-aberrant transcripts or proteins. Additionally,
some of the negative results were due to incorrect gene models that generated spurious
stop codons, but even after stringently filtering both sequence data and gene models, it is
clear that many strong sequence variants are successfully buffered at intermediate
levels[284-286]. These silent and negative results are highly useful in evaluating the
reported impact of major alleles. An example is a splice site mutation in Cyp2c39 that
inactivates this P450 enzyme and essentially eliminates expression. This mutation has no
detectable impact on higher order phenotypes, a compelling negative result. An obvious
explanation in this case is functional overlap with other members of the Cyp2c cluster,
but we still do not have sufficient knowledge to understand the molecular basis of
resilience. Another explanation is that combinations of deleterious variants in molecular
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and developmental network will have much more notable phenotypic effects than isolated
mutations. In retrospect, this buffering of genetic variation is not surprising. A large
fraction of knockout mutations in mice and other well-typed species are viable and many
of these do not have any known functional consequences [287,288].
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CHAPTER 5.

SUMMARY

In this dissertation, I have described and performed first phenome-wide
association analysis (PheWAS) on a genetically diverse murine population. PheWAS is a
novel reverse genetics approach to link sequence variants to a spectrum of phenotypes
and diseases, and several studies have successfully used it on human clinical cohorts
[59,267]. In order to extend the approach to an experimental cohort, I used a large
population of BXD recombinant inbred strains, for which we generated, assembled, and
annotated key genetic, genomics, proteomics, and phenome data.
In chapter 2, I explored the genetic variation between the parental strains of the
BXD population by analyzing high-throughput sequence data for the DBA/2J strain. This
study revealed that BXD progeny are segregating for considerable genetic variation
including 4.46 million SNPs, 0.94 million indels, and 20,000 high confidence structural
variants. The comprehensive annotation of these variants against mouse gene model
(RefSeq) revealed that vast majority of them occur within intergenic (45%) and intronic
(28%) regions. Around 40,000 variants occur within exons and a subset of which belongs
to high-impact category including 61 nonsense, 196 splice-site, 99 frameshifts and 10,895
missense mutations. The high-impact coding variants that I uncovered provide an
unprecedented resource with which to establish genome to phenome relations in a
remarkably large and stable set of BXD lines.
In chapter 3, I explored the functional impact of genetic variation on gene
expression by performing allele-specific gene expression (ASE) analysis using liver
RNA-seq data from isogenic F1 hybrids. This study revealed that cis acting variation in
expression is pervasive and is detected in roughly 50% of all assayable genes. Over onethird of them differ in expression greater than two-fold. This study also revealed that
genes exhibiting strong ASE differences have a higher density of sequence variants,
higher functional redundancy, and lower evolutionary conservation compared to genes
with no ASE. Genes exhibiting high ASE differences in conjugation with high-impact
coding variants (Chapter 2) should be key molecular resources for reverse genetics
analysis.
In chapter 4, I exploited list of high-impact genetic variants (genes) that I
generated in chapters two and three to perform a phenome-wide association study to
investigate genome-to-phenome relations at multiple scales²from mRNA and protein
levels to disease risk, behavior, and environmental interactions. We also exploited a large
human clinical cohort²the Vanderbilt BioVU cohort² for validation and cross species
translation of the novel associations. We successfully replicated almost all of the known
genome-to-phenome associations in BXDs that were previously identified using forward
genetics approach, and also identified a few novel associations. For example, we linked a
missense mutation in fumarate hydratase that controls variation in the mitochondrial
unfolded protein response in both mouse and C. elegans, and missense mutations in
Col6a5 that underlies variation in bone mineral density in both mouse and human.
However, downstream effects of allelic variants with presumed deleterious effects on
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gene expression or protein structure are often small or undetectable. This may often be
due to a lack of technical sensitivity and power or to phenotypic buffering. We
demonstrate that phenome scans can be effective at linking sequence variants to a range
of phenotypes and can be used to identify novel genome-to-phenome relations or validate
hypothesized associations from independent studies. Coupling mouse and human
PheWAS cohorts also shows great promise, and provides an efficient method to validate
and translate key genome-to-phenome relations.
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